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GENERAL INTRODUCTION 
 
Introduction 
   Arynes are one of the most interesting species in organic synthesis because of their 
remarkably high reactivity. Although the structures of arynes were confirmed more than 
sixty years ago, the study of aryne chemistry was largely hindered by the harsh conditions 
needed to generate these reactive intermediates. Very recently, the discovery of o-
silylaryl triflates, which can generate the corresponding arynes under very mild 
conditions, opened the way for a more thorough investigation into the remarkable 
chemistry of arynes. In the past several years in the Larock group, many aspects of the 
chemistry of arynes have been studied systematically and a variety of useful synthetic 
methodologies employing arynes have been discovered. The simple arylation of amines, 
phenols, carboxylic acids, carbamates, and sulfonamides by arynes was investigated first. 
It has also been discovered that the carbanion generated from nucleophilic attack on an 
aryne is able to further attack a neighboring electrophile to afford cyclization products. 
These tandem coupling-cyclization reactions have been employed to prepare various 
heterocycles exhibiting interesting biological activities. Furthermore, many heterocycles 
can be easily synthesized by the [3+2] cycloaddition of arynes by 1,3-dipoles. This 
dissertation reports in Chapters 1 and 2 one new methodology in each of the last two 
areas. 
   Palladium-catalyzed reactions have found numerous applications in organic synthesis, 
especially in processes involving C-C bond or C-X bond formation. The Larock research 
group has developed numerous palladium-mediated annulations, which generally involve 
multiple bond formation. These methodologies afford efficient and general protocols for 
the preparation of biologically active heterocycles. In the last several years, the Larock 
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group and other groups have been extending these metal-catalyzed annulation processes 
to arynes. By taken advantage of both the high reactivity of arynes and the high catalytic 
activity of palladium, polycyclic aromatic and heteroaromatic hydrocarbons can be 
synthesized from aryl halides. Chapters 3 and 4 describe two new palladium-catalyzed 
annulation reactions of arynes with aryl halides, in which C-C and C-N bonds can be 
formed simultaneously. The methods presented in this dissertation cover different areas of 
aryne chemistry and certainly underscore the synthetic versatility of arynes. 
Dissertation Organization 
    This dissertation is divided into four chapters. Each chapter presented herein is written 
as a manuscript, which follows the guidelines for a full paper in the Journal of Organic 
Chemistry, and is composed of an abstract, introduction, results and discussion, 
conclusions, experimental section, acknowledgements and references. 
    Chapter 1 reports the synthesis of 9-substituted xanthenes from the coupling-
cyclization of silylaryl triflates and o-hydroxychalcones in the presence of CsF. This 
chemistry presumably proceeds by a tandem intermolecular nucleophilic coupling of the 
phenoxide ion with an aryne and subsequent intramolecular Michael addition.  
    Chapter 2 describes the [3+2] cycloaddition of a variety of nitrones with arynes 
generated from o-silylaryl triflates in the presence of CsF. This process affords a wide 
variety of benzisoxazolines in good to excellent yields. 
    Chapter 3 reports a novel palladium-catalyzed annulation of arynes by o-
halobenzamides, which involves simultaneous C-C and C-N bond formation to provide a 
novel way to synthesize a variety of phenanthridinones. 
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    Chapter 4 describes a novel palladium-catalyzed annulation of arynes by o-
haloacetanilides in the presence of CsF, which provides a novel route to a variety of N-
acylcarbazoles.  
    Finally, all of the 1H and 13C NMR spectra for the new starting materials and reaction 
products have been compiled in appendices A-D, following the general conclusions for 
this dissertation. 
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CHAPTER 1. Synthesis of 9-Substituted Xanthenes 
by the Condensation of Arynes with ortho-Hydroxychalcones 
 
Chun Lu and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, IA 50011 
 
 
Abstract 
    The reaction of o-(trimethylsilyl)aryl triflates, CsF, and o-hydroxychalcones affords a 
general and efficient way to prepare biologically interesting 9-substituted xanthenes. This 
chemistry presumably proceeds by tandem intermolecular nucleophilic attack of the 
phenoxide of the chalcone on the aryne and subsequent intramolecular Michael addition. 
The introduction of an external base, Cs2CO3, has proven beneficial in this reaction. 
Introduction 
 From some of the oldest known dyes1 to newly developed agriculturally- and  
pharmaceutically-interesting intermediates,2 xanthenes have attracted attention for 
decades and continue to be the focus of biological and material science studies today. 
 Many naturally-occurring and man-made xanthene derivatives have been reported to 
exhibit extraordinary biological activities, including anti-malarial,3 anti-trypanosomal,4 
anti-leishmanial,4 and anti-tumor5 activities. More recently, the notable fluorescent 
properties of xanthenes have received attention.  For example, xanthene derivatives have 
been prepared as fluorescent probes,6  and electrostatic sensors.7  
    The synthesis of xanthene derivatives has also been widely studied. There are several 
well established approaches to xanthene derivatives,8  which typically feature formation 
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of the central heterocyclic ring, often by combinations of Friedel-Crafts methodology and 
C-O bond formation. Xanthenes can also be obtained by reduction of the corresponding 
xanthones.9 However, most of these synthetic approaches involve either multistep 
procedures or fairly harsh reaction conditions.  
    Since a convenient approach to aryne generation by the fluoride-induced 1,2-
elimination of o-(trimethylsilyl)aryl triflates was first reported in 1983,10  the reactivity of 
arynes, especially their electrophilicity, has been explored extensively. For example, in 
our group, in situ generated benzyne has been coupled with simple nucleophiles, such as 
amines, sulfonamides, phenols and arenecarboxylic acids,11  to generate monosubstituted 
arenes. Besides those simple coupling reactions, insertion processes (Scheme 1) have  
Scheme 1 
                         
been reported for nucleophiles bearing neighboring electrophiles, such as ureas,12 keto 
esters,13 amides,14 sulfonamides,14 and acid halides.15 We have been particularly 
interested in annulation processes, which rapidly construct biologically-interesting ring 
systems by simple tandem processes. For example, we have reported that salicylates and 
in situ generated arynes readily react to form heteroatom ring systems, such as xanthones, 
thioxanthones and acridones (Scheme 2).16 
Scheme 2 
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 Herein, we present a novel coupling reaction between o-hydroxychalcones and o-
(trimethylsilyl)aryl triflates, which provides a new method for the synthesis of 9-
substituted xanthenes in a simple one step process under very mild reaction conditions.17 
During the course of our work, related chemistry has recently been reported.18  
Results and Discussion 
Optimization Studies  
    Our optimization work was carried out using commercially available o-
hydroxychalcone 1a and o-(trimethylsilyl)phenyl triflate (2a) under a variety of different 
reaction conditions (Table 1). We first examined some commonly used benzyne reaction  
Table 1. Optimization Studiesa  
 
entry CsF 
(equiv) 
solvent temp 
(oC) 
additive 
(equiv) 
% yieldb 
3a (4a) 
       
1 
 
 
2.0 
 
 
MeCN 
 
rt 
 
-------- 
 
32 (68) 
2 2.0 TBAFc THF rt -------- 17 (65) 
3 2.0 THF rt -------- traced 
4 2.0 THF 65 -------- 60 (17) 
5 3.0 THF 65 -------- 67 
6 5.0 THF 65 -------- 74 
7 3.0 THF 65 1.0 Cs2CO3 80 
aReactions were conducted on a 0.25 mmol scale  with 1.2 equiv of 2a in 10 ml of solvent 
for 24 h. bYields of products isolated by column chromatography. cTBAF  (1M in THF). 
d Very low conversion. 
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conditions, namely MeCN as the solvent with added CsF (entry 1), and THF solvent with 
TBAF19 (entry 2). Not surprisingly,11 our initial studies indicated that significant amounts 
of the corresponding phenyl ether 4a were generated alongside 3a, which was produced 
in only a low yield. When employing CsF in THF solvent (entry 3), although the reaction 
proceeded in very low conversion, the desired product 3a was generated as the major 
product, which suggested that THF was able to suppress proton abstraction.16  By raising 
the temperature to 65 ºC (entry 4), the reaction could be completed in 24 h and a 60% 
yield was produced. Interestingly, we observed that as the amount of the base CsF added 
to the system was increased (entries 5 and 6), the yield improved. Finally, with the 
addition of 1 equiv of Cs2CO3 (entry 7), the yield was improved to 80%. Other bases, 
such as Li2CO3 and K2CO3, were also tested, but none of them was as effective as 
Cs2CO3. Thus, the reaction conditions reported in entry 7 (3 equiv of CsF, 1 equiv of 
Cs2CO3 in THF solvent at 65 °C) were chosen as our optimal conditions for further study.  
Synthesis of 9-Substituted Xanthenes      
We next examined a wide range of o-hydroxychalcones bearing various functional 
groups (Table 2). Chalcones with electron-donating methoxy (entry 2) and methyl (entry 
3) substituents provided decent yields, 74% and 64%, respectively. A fluoro-substituted 
chalcone (entry 4) also afforded good results. Substrates with other electron-withdrawing 
groups, such as I
 
(entry 5), Br (entry 6), and NO2 (entry 7) groups, resulted in much lower 
yields under our “optimal” conditions. However, by simply removing the Cs2CO3 base  
(1.2 equiv of 2a, 3.0 equiv of CsF, THF, 65 ºC), the yields can be improved significantly. 
This is probably because phenoxide anions bearing electron-withdrawing groups can be 
generated in substantial amounts when Cs2CO3 is present, which favors the formation of 
the side products (see the mechanistic discussion). 
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Table 2.  Reaction Scope with Different Chalcone Derivativesa 
 
entry chalcone R X product / yield (%) b 
1 1a H C(O)Ph 3a / 80 
2 1b OMe C(O)Ph 3b / 74 
3 1c Me C(O)Ph 3c / 64 
4 1d F C(O)Ph 3d / 84 
5 1e I C(O)Ph 3e / 60 (78)c 
6 1f Br C(O)Ph 3f / 58 (75)c 
7 1g NO2 C(O)Ph 3g / 41 (70)c 
8 1h H C(O)C6H4(OMe)-p 3h / 61 
9 1i H    C(O)C6H4I-p 3i / 73 
10 1j H C(O)Me 3j / 71 
11 1k H C(O)t-Bu 3k / 65 
12 1l H C(O)C6H11 3l / 64 
13 1m H CHO 3m / 60 
13 1n H CN 3n / 70 
15 1o H CO2t-Bu 3o / 60d 
16 1p H SO2Ph 3p / 15 (51)e 
 
a Reactions were conducted on a 0.25 mmol scale for 24 h. b Yields of products isolated 
by column chromatography. c Reactions were conducted with 1.2 equiv of 2a, 3.0 equiv 
of  CsF and THF (10 ml)  at 65 oC. d 1H NMR spectroscopic yield. e This reaction was 
conducted with 2.0 equiv of 2a, 3.0 equiv of  CsF, THF (10 ml)  at 45 oC for 30 h. 
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     The effect of the group X on the carbon-carbon double bond has also been examined. 
Decent yields were provided by substrates with different acyl groups (entries 8-12). 
Aldehyde (entry 13) and cyano (entry 14) groups are also tolerated. For the substrate with 
an ester group (entry 15), an inseparable mixture of the desired product and arylation side 
product was generated. For reasons that are not obvious, a sulfonyl group does not 
activate the Michael acceptor sufficiently in this chemistry to produce a good yield. The 
use of additional benzyne precursor, a lower temperature and a longer reaction time were 
necessary to get a decent yield (entry 16). 
    The behavior of the  aryne precursors 2b, 2c, and 2d (Table 3) has also been examined  
Table 3. Reaction with Different Benzyne Precursorsa 
 
entry aryne precursor                 product / % yieldb 
1 
 
2b  3q / 51 
 
 
2 
 
 
MeO
MeO TMS
OTf
 
2c  3r / 46c 
 
3 
 
 
 
 
2d 
 
 
3s / 57 
aRections were conducted on a 0.25 mmol scale for 24 h in 10 ml of THF. 
bYields of products isolated by column chromatography. cThe reaction time was 
48 h. 
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in this reaction. All of these substrates generated lower yields than benzyne itself, perhaps 
due to slower aryne generation. We have observed that aryne precursor 2d affords a 
single isomeric product 3s. This regioselectivity for 3-methoxybenzyne has been seen 
previously in our group and by others.20  
 Based on the experimental results and previous studies,11,16 we postulate that this 
coupling reaction proceeds in the following manner (Scheme 3). The intermediate C  
Scheme 3.  Possible Mechanism 
 
 
generated from nucleophilic coupling of the aryne and the aryl oxide undergoes 
intramolecular Michael addition to afford the desired xanthene B after protonation. 
However, well known H abstraction by C could lead to diaryl ether A, which has been 
observed by us as the major side product for most of the substrates examined in this 
reaction. Since the proton abstraction of C is quite fast, a competition is present between 
intramolecular cyclization and intermolecular proton abstraction. In order to supress this 
side reaction, dry reaction conditions and the addition of an extra base are necessary. This 
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helps to remove the acidic protons present before intermediate C is able to react with the 
proton and generate the side product A.   
Conclusions 
    In conclusion, we have demonstrated that o-hydroxychalcones and related compounds 
undergo annulation reactions with o-(trimethylsilyl)aryl triflates through tandem 
nucleophilic coupling  and subsequent Michael addition. This reaction affords a general 
one-pot approach to 9-substituted xanthenes from readily prepared starting materials. 
Mild reaction conditions allow a variety of functional groups to be tolerated in this 
reaction. With carbonyl and other functionalities in the products, further elaboration can 
easily be achieved.  
Experimental Section 
General 
   The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 and 100 MHz 
respectively. All melting points are uncorrected. High resolution mass spectra were 
recorded using EI at 70 eV. All reagents were used directly as obtained commercially 
unless otherwise noted. All reactions were carried out in oven-dried glassware and 
monitored by thin layer chromatography (SiO2, hexanes or hexanes/EtOAc). THF was 
distilled over Na. The silylaryl triflate 1a, CsF, TBAF solution (1M in THF) and 
acetonitrile were purchased from Sigma-Aldrich Co. The 4,5-dimethyl-substituted 
silylaryl triflate 2b, 4,5-dimethoxy-substituted silylaryl triflate 2c and 3-methoxy-
substituted silylaryl triflate 2d were prepared according to a literature procedure.
21
 
Non-commercial compounds 
    Non-commercially available starting materials were prepared according to literature 
procedures.22  
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3-(2-Hydroxy-5-methoxyphenyl)-1-phenyl-2-propen-1-one (1b): yellow solid, mp 95-
97 °C; 1H NMR (400 MHz, d6-acetone) δ 8.81 (s, 1H), 8.20 (d, J = 12.0 Hz, 1H), 8.16 (m, 
2H), 7.90 (d, J = 16.0 Hz, 1H), 7.57 (m, 3H), 7.40 (s, 1H), 6.93 (m, 2H), 3.80 (s, 3H); 13C 
NMR (400 MHz, d6-acetone) δ 189.75, 153.48, 151.45, 139.79, 138.76, 132.83, 128.85, 
128.58, 122.50, 121.80, 118.85, 117.37, 112.29, 55.42; HRMS (EI) calcd for C16H14O3: 
254.0943, found 254.0947. 
 
3-(2-Hydroxy-5-methyl)-1-phenyl-2-propen-1-one (1c): yellow solid, mp 143-145 °C; 
1H NMR (300 MHz, d6-acetone) δ 8.99 (s, 1H), 8.19 (d, J = 15.0 Hz, 1H), 8.11 (m, 2H), 
7.88 (d, J =  15.0 Hz, 1H), 7.58 (m, 4H), 7.10 (dd, J = 3.0, 9.0 Hz, 1H), 6.90 (d, J = 9.0 
Hz, 1H), 2.28 (s, 3H); 13C NMR (300 MHz, d6-acetone) δ 189.68, 155.17, 139.99, 138.84, 
132.75, 129.15, 128.84, 128.52, 121.90, 121.43, 116.35, 19.84; HRMS (EI) calcd for 
C16H14O2: 238.0994, found 238.0996. 
 
3-(5-Fluoro-2-hydroxy)-1-phenyl-2-propen-1-one (1d): yellow solid, mp 177-179 °C; 
1H NMR (300 MHz, d6-acetone) δ 9.21 (s, 1H), 8.16 (m, 3H), 7.93 (d, J = 15.0 Hz, 1H), 
7.62 (m, 4H), 7.05 (m, 2H); 13C NMR (300 MHz, d6-acetone) δ 189.36, 157.84, 153.42, 
138.53, 138.27, 138.24, 132.96, 128.86, 128.62, 123.33, 123.25, 122.68, 118.49, 118.25, 
117.53, 117.45, 114, 05, 113.83; HRMS (EI) calcd for C15H11O2F: 242.0743, found 
242.0747. 
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3-(2-Hydroxy-5-iodo)-1-phenyl-2-propen-1-one (1e): yellow solid, mp 164-165 °C; 1H 
NMR (300 MHz, d6-acetone) δ 9.51 (s, 1H), 8.16 (m, 3H), 8.08 (d, J = 15.0 Hz, 1H), 7.95 
(d, J = 15.0 Hz, 1H), 7.60 (m, 4H), 6.86 (d, J = 6.0 Hz, 1H); 13C NMR (300 MHz, d6-
acetone) δ 189.36, 156.96, 140.22, 138.51, 137.79, 137.05, 132.97, 128.87, 128.65, 
125.15, 122.72, 118.87, 81.51. HRMS (EI) calcd for C15H11O2I: 349.9804, found 
349.9802. 
 
3-(5-Bromo-2-hydroxy)-1-phenyl-2-propen-1-one (1f): yellow solid, mp 165-166 °C; 
1H NMR (300 MHz, d6-acetone) δ 9.49 (s, 1H), 8.10 (m, 5H), 7.61 (m, 3H), 7.41 (d, J = 
9.0 Hz, 1H), 6.98 (d, J = 9.0 Hz, 1H); 13C NMR (300 MHz, d6-acetone) δ 189.31, 156.27, 
138.49, 137.78, 134.24, 132.98, 130.94, 128.87, 128.65, 124.57, 122.84, 118.40, 111.80. 
HRMS (EI) calcd for C15H11O2Br: 302.9932, found 302.9933. 
 
1-(2-Hydroxyphenyl)-4,4-dimethylpent-1-en-3-one (1k): white solid, mp 115-117 °C; 
1H NMR (400 MHz, d6-acetone) δ 9.09 (s, 1H), 8.01 (d, J = 16.0 Hz, 1H), 7.69 (d, J = 8.0 
Hz, 1H), 7.43 (d, J = 16.0 Hz, 1H), 7.24 (t, J = 8.0 Hz, 1H), 6.97 (d, J = 8.0 Hz, 1H), 6.88 
(t, J = 8.0 Hz, 1H), 1.20 (s, 9H); 13C NMR (400 MHz, d6-acetone) δ 203.35, 157.00, 
137.77, 131.51, 128.94, 122.27, 121.03, 120.12, 116.34, 42.98, 25.94. HRMS (EI) calcd 
for C13H16O2: 204.1150, found 204.1154. 
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1-Cyclohexyl-3-(2-hydroxyphenyl)-2-propen-1-one (1l): white solid, mp 163-165 °C; 
1H NMR (300 MHz, d6-acetone) δ 9.10 (s, 1H), 7.95 (d, J = 18.0 Hz, 1H), 7.65 (d, J = 9.0 
Hz, 1H), 7.25 (t, J = 9.0 Hz, 1H), 7.03 (d, J = 18.0 Hz, 1H), 6.96 (d, J = 6.0 Hz, 1H), 6.89 
(t, J = 9.0 Hz, 1H), 2.71 (m, 1H), 1.75 (m, 5H), 1.35 (m, 5H); 13C NMR (300 MHz, d6-
acetone) δ 202.10, 156.89, 137.06, 131.51, 128.72, 124.88, 122.04, 120.17, 116.32, 49.07, 
29.19, 26.08, 25.76. HRMS (EI) calcd for C15H18O2: 230.1307, found 230.1312. 
Representative procedure for the condensation of arynes with o-hydroxychalcones 
o-Hydroxychalcone (0.25 mmol), the silylaryl triflate (0.3 mmol), CsF (0.75 mmol) and 
Cs2CO3 (0.25 mmol) in 10 ml of anhydrous THF were stirred at 65 °C for about 24 h. The 
reaction mixture was allowed to cool to room temperature, diluted with ethyl acetate and 
washed with brine. The aqueous layer was re-extracted with ethyl acetate. The organic 
layers were combined, dried (MgSO4), filtered, and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography on silica gel. 
 
2-(2-Methoxy-9H-xanthen-9-yl)-1-phenylethanone (3b): white solid, mp 128-129 °C; 
1H NMR (300 MHz, CDCl3) δ 7.81 (d, J = 7.5 Hz, 2H), 7.50 (t, J = 7.5 Hz, 1H), 7.35 (m, 
3H), 7.20 (t, J = 6.0 Hz, 1H), 7.05 (m, 3H), 6.85 (d, J = 3.0 Hz, 1H), 6.77 (dd, J = 3.0, 9.0 
Hz, 1H), 4.83 (t, J = 6.0 Hz, 1H), 3.74 (s, 3H), 3.36 (dd, J = 3.0, 6.0 Hz, 2H); 13C NMR 
(300 MHz, CDCl3) δ 198.16, 155.72, 152.78, 146.55, 137.14, 133.35, 128.96, 128.72, 
128.29, 128.03, 126.35, 125.26, 123.44, 117.45, 116.67, 114.19, 113.05, 55.89, 49.79, 
35.30; HRMS (EI) calcd for C22H18O3: 330.1256, found 330.1253. 
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2-(2-Methyl-9H-xanthen-9-yl)-1-phenylethanone (3c): white solid, mp 82-83 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.81 (m, 2H), 7.50 (t, J = 9.0 Hz, 1H), 7.35 (m, 3H), 7.20 (t, J 
= 8.0 Hz, 1H), 7.10 (m, 2H), 7.01 (m, 3H), 4.81 (t, J = 6.0 Hz, 1H), 3.35 (d, J = 6.0 Hz, 
2H), 2.27 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 198.16, 152.65, 150.38, 137.19, 133.28, 
133.02, 129.21, 129.04, 128.68, 128.63, 128.27, 127.97, 125.71, 125.36, 123.45, 116.68, 
116.41, 49.96, 34.85, 20.91; HRMS (EI) calcd for C22H18O2: 314.1307, found 314.1307. 
 
2-(2-Fluoro-9H-xanthen-9-yl)-1-phenylethanone (3d): white solid, mp 114-115 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.82 (m, 2H), 7.51 (t, J = 9.0 Hz, 1H), 7.31 (m, 4H), 7.08 (m, 
4H), 6.91 (td, J = 3.0, 7.5 Hz, 1H), 4.84 (t, J = 6.0 Hz, 1H), 3.37 (dd, J = 3.0, 6.0 Hz, 2H); 
13C NMR (300 MHz, CDCl3) δ 197.59, 160.34, 157.14, 152.49, 148.61, 136.93, 133.45, 
128.85, 128.75, 128.24, 128.22, 127.13, 127.03, 124.84, 123.84, 117.85, 117.73, 116.71, 
115.34, 115.03, 114.96, 114.65, 49.60, 34.78; HRMS (EI) calcd for C21H15O2F: 
318.1056, found 318.1055. 
 
2-(2-Iodo-9H-xanthen-9-yl)-1-phenylethanone (3e): white solid, mp 133-134 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.80 (d, J = 7.8 Hz, 2H), 7.63 (s, 1H), 7.53-7.18 (m, 6H), 7.06 
(m, 2H), 6.86 (d, J = 8.4 Hz, 1H), 4.78 (t, J = 6.0 Hz, 1H), 3.34 (d, J = 6.0 Hz, 2H); 13C 
NMR (300 MHz, CDCl3) δ 197.50, 152.45, 152.07, 137.58, 136.90, 133.45, 129.01, 
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128.75, 128.25, 125.05, 123.96, 118.95, 116.76, 115.72, 49.78, 34.42; HRMS (EI) calcd 
for C21H15O2I: 426.0117, found 426.0127. 
 
2-(2-Bromo-9H-xanthen-9-yl)-1-phenylethanone (3f): white solid, mp 131-132 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.81 (m, 2H), 7.48 (m, 2H), 7.39 (t, J = 7.2 Hz, 4H), 7.25 (m, 
4H), 7.06 (m, 2H), 6.99 (d, J = 8.1 Hz, 1H), 4.81 (t, J = 6.6 Hz, 1H), 3.37 (d, J = 6.6 Hz, 
2H); 13C NMR (300 MHz, CDCl3) δ 197.50, 152.16, 151.66, 136.94, 133.48, 131.66, 
130.99, 130.26, 128.98, 128.84, 128.77, 128.27, 127.83, 124.99, 123.99, 118.53, 116.77, 
115.72, 49.78, 34.42; HRMS (EI) calcd for C21H15O2Br: 379.0244, found 379.0249. 
 
2-(2-Nitro-9H-xanthen-9-yl)-1-phenylethanone (3g): white solid, mp 133-135 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.29 (d, J = 2.4 Hz, 1H), 8.11 (dd, J = 9.0, 3.0 Hz, 1H), 7.83 
(m, 2H), 7.52 (t, J = 7.5 Hz, 1H), 7.24 (m, 8H), 4.92 (t, J = 6.0 Hz, 1H), 3.44 (d, J = 6.0 
Hz, 2H); 13C NMR (300 MHz, CDCl3) δ 196.92, 157.23, 151.37, 143.57, 136.68, 133.67, 
128.89, 128.85, 128.67, 128.25, 126.29, 125.42, 124.92, 124.15, 124.09, 117.50, 116.95, 
49.65, 34.17; HRMS (EI) calcd for C21H15O4N: 345.1001, found 345.1002. 
 
1-(4-Methoxyphenyl)-2-(9H-xanthen-9-yl)ethanone (3h): white solid, mp 111-112 °C; 
1H NMR (300 MHz, CDCl3) δ 7.79 (m, 2H), 7.34 (d, J = 7.5 Hz, 2H), 7.22 (t, J = 6.0 Hz, 
2H), 7.13 (d, J = 7.5 Hz, 1H), 7.03 (td, J = 7.5, 1.2 Hz, 2H), 6.84 (m, 2H), 4.86 (t, J = 6.0 
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Hz, 1H), 3.83 (s, 3H), 3.31 (d, J = 6.0 Hz, 2H); 13C NMR (300 MHz, CDCl3) δ 196.56, 
163.64, 152.47, 130.57, 130.28, 129.04, 127.97, 125.80, 123.62, 116.68, 113.80, 55.62, 
49.55, 34.93; HRMS (EI) calcd for C22H18O3: 330.1256, found 330.1256. 
 
1-(4-Iodophenyl)-2-(9H-xanthen-9-yl)ethanone (3i): white solid, mp 129-131 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.79 (m, 2H), 7.34 (d, J = 7.5 Hz, 2H), 7.22 (t, J = 6.0 Hz, 
2H), 7.13 (d, J = 7.5 Hz, 1H), 7.03 (td, J = 7.5, 1.2 Hz, 2H), 6.84 (m, 2H), 4.86 (t, J = 6.0 
Hz, 1H), 3.83 (s, 3H), 3.31 (d, J = 6.0 Hz, 2H); 13C NMR (300 MHz, CDCl3) δ 197.42, 
152.49, 137.97, 136.34, 129.63, 128.93, 128.15, 125.46, 123.70, 116.79, 101.39, 49.63, 
34.93; HRMS (EI) calcd for C21H15O2I: 426.0117, found 426.0125. 
 
1-tert-Butyl-2-(9H-xanthen-9-yl)ethanone (3k): white solid, mp 86-87 °C; 1H NMR 
(300 MHz, CDCl3) δ 7.21 (m, 4H), 7.10 (m, 2H), 7.03 (td, J = 6.0, 1.5 Hz,  2H), 4.68 (t, J 
= 6.0 Hz, 1H), 2.81 (d, J = 6.0 Hz, 2H), 0.89 (s, 9H); 13C NMR (300 MHz, CDCl3) δ 
213.48, 152.52, 128.82, 127.96, 125.90, 123.59, 116.66, 48.04, 44.50, 34.86, 25.70; 
HRMS (EI) calcd for C19H20O2: 280.1463, found 280.1463. 
 
1-Cyclohexyl-2-(9H-xanthen-9-yl)ethanone (3l): colorless oil; 1H NMR (300 MHz, 
CDCl3) δ 7.21 (m, 4H), 7.04 (m, 4H), 4.64 (t, J = 6.0 Hz, 1H), 2.79 (d, J = 6.0 Hz, 2H), 
2.04 (m, 1H), 1.63 (m, 5H), 1.11 (m, 5H); 13C NMR (300 MHz, CDCl3) δ 211.91, 152.39, 
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128.82, 127.97, 125.76, 123.60, 116.67, 51.90, 51.85, 34.59, 27.94, 25.95, 25.68; HRMS 
(EI) calcd for C21H22O2: 306.1620, found 306.1623. 
 
 9H-Xanthene-9-acetic acid, tert-butyl ester (3o): colorless oil, 1H NMR (300 MHz, 
CDCl3) δ 7.25 (m, 4H), 7.06 (m, 4H), 4.50 (t, J = 6.0 Hz, 1H), 2.60 (d, J = 6.0 Hz, 2H), 
1.25 (s, 9H); 13C NMR (300 MHz, CDCl3) δ 170.78, 152.28, 128.77, 128.13, 124.69, 
123.46, 116.72, 80.99, 47.01, 35.92, 28.15; HRMS (EI) calcd for C19H20O3: 296.1412, 
found 296.1402. 
 
9-(Phenylsulfonyl)methyl-9H-xanthene (3p): white solid, mp 129-131 °C; 1H NMR 
(300 MHz, CDCl3) δ 7.94 (m, 1H), 7.84 (m, 2H), 7.50 (m, 3H), 7.37 (d, J = 7.5 Hz, 2H), 
7.23 (td, J = 7.5, 1.5 Hz, 2H) , 7.08 (d, J = 7.5 Hz, 3H), 4.86 (t, J = 5.7 Hz, 1H), 3.42 (d, J 
= 5.7 Hz, 2H); 13C NMR (300 MHz, CDCl3) δ 152.37, 140.18, 133.86, 133.36, 129.48, 
129.30, 128.76, 127.93, 127.83, 123.95, 123.28, 116.88, 65.56, 33.77; HRMS (EI) calcd 
for C20H16O3S: 336.0820, found 336.0810. 
 
2-(2,3-Dimethyl-9H-xanthen-9-yl)-1-phenylethanone (3q): white solid, mp 95-97 °C; 
1H NMR (300 MHz, CDCl3) δ 7.79 (m, 2H), 7.48 (t, J = 6.0 Hz, 1H), 7.31 (m, 3H), 7.17 
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(t, J = 6.0 Hz, 1H), 7.06 (m, 2H) , 6.98 (t, J = 6.0 Hz, 1H), 6.90 (s, 1H), 4.78 (t, J = 6.0 
Hz, 1H), 3.33 (d, J = 6.0 Hz, 2H), 2.21 (s, 3H), 2.16 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 198.27, 166.55, 152.66, 150.38, 137.23, 136.50, 133.24, 131.75, 129.58, 
129.07, 128.67, 128.28, 127.89, 125.81, 123.32, 122.62, 117.49, 116.68, 50.19, 34.37, 
19.79, 19.21; HRMS (EI) calcd for C23H20O2: 328.1126, found 328.1121. 
 
2-(2,3-Dimethoxy-9H-xanthen-9-yl)-1-phenylethanone (3r): white solid, mp 138-140 
°C; 1H NMR (300 MHz, CDCl3) δ 7.81 (d, J = 9.0 Hz, 2H), 7.50 (t, J = 9.0 Hz, 1H), 7.40-
7.18 (m, 4H), 7.10-6.99 (m, 2H), 6.79 (s, 1H) , 6.68 (s, 1H), 4.80 (t, J = 6.0 Hz, 1H), 3.87 
(s, 3H), 3.78 (s, 3H), 3.33 (d, J = 6.0 Hz, 2H); 13C NMR (300 MHz, CDCl3) δ 198.61, 
152.53, 148.73, 146.12, 145.28, 137.21, 133.37, 128.95, 128.72, 128.29, 127.94, 125.34, 
123.53, 116.58, 115.92, 111.18, 100.77, 56.46, 56.19, 50.19, 34.62; HRMS (EI) calcd for 
C23H20O4: 360.1218, found 360.1219. 
 
2-(1-Methoxy-9H-xanthen-9-yl)-1-phenylethanone (3s): white solid, mp 125-127 °C; 
1H NMR (300 MHz, CDCl3) δ 7.80 (m, 2H), 7.50 (t, J = 6.0 Hz, 1H), 7.33 (m, 3H), 7.20 
(t, J = 6.0 Hz, 1H), 7.03 (m, 3H), 6.84 (d, J = 3.0 Hz, 1H) , 6.75 (dd, J = 9.0, 3.0 Hz, 1H), 
4.82 (t, J = 6.0 Hz, 1H), 3.73 (s, 3H), 3.35 (d, J = 6.0 Hz, 2H); 13C NMR (300 MHz, 
CDCl3) δ 198.16, 152.72, 152.78, 146.55, 137.15, 133.35, 128.96, 128.72, 128.29, 
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128.03, 126.35, 125.26, 123.44, 117.45, 116.67, 114.19, 113.05, 55.89, 49.79, 35.30; 
HRMS (EI) calcd for C22H18O3: 330.1312, found 330.1318. 
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by the Highly Efficient Coupling of Arynes with Nitrones 
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Abstract 
     A variety of substituted benzisoxazolines have been synthesized by the [3+2] 
cycloaddition of nitrones and arynes. The reaction scope is broad, the reaction conditions 
are mild, and the process tolerates a variety of functional groups. 
Introduction 
 Benzisoxazoline is a critical sub-unit in pharmaceuticals with important biological and 
pharmacological activities, including antimicrobial activity against Salmonella paratyphi, 
Proteus vulgaris, Xanthomonas spp., Fusarium solanii, and Botrytis cinerea.1 
Benzisoxazolines can also be important synthetic intermediates for the preparation of 
more complex molecules.2 Much effort has been devoted to the synthesis of this 
heterocyclic ring system.3  
 Since a convenient approach to aryne generation by the fluoride induced 1,2-
elimination of o-(trimethylsilyl)aryl triflates was first reported,4 highly electrophilic 
arynes have been employed extensively in recent years for the construction of many 
heteroaromatic structures.5 Our group has recently reported that simple nucleophilic 
reactions,6 annulation reactions of ortho-heteroatom (N, O, and S)-substituted benzoates7 
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and a variety of 1,3-dipolar cycloadditions8 provide useful new synthetic routes to a 
variety of heterocycles, generally affording excellent yields under mild reaction 
conditions. In a continuation of our work on the reactions of arynes with dipoles, we have 
investigated the cycloaddition reactions of nitrones and arynes. During this project, 
related work was communicated by other groups,9 although the reaction conditions are 
different. Herein, we wish to report our more detailed and extensive results of the 1,3-
dipolar cycloaddition reaction of nitrones and arynes to afford substituted 
benzisoxazolines.10 
Results and Discussion 
Optimization Studies 
We optimized the reaction conditions for the reaction of the unsubstituted benzyne 
precursor o-(trimethylsilyl)phenyl triflate (1a) and N-benzylidenebenzylamine N-oxide 
(2a) (Table 1). Employing acetonitrile as the solvent and 3.0 equiv of CsF as the fluoride 
source, adding more CsF or more benzyne precursor failed to improve the yield 
significantly, presumably due to the fast generation of benzyne in acetonitrile (entries 1-
3). Another fluoride ion source, TBAF,11 was also examined (entries 4 and 5). By 
utilizing 2.0 equiv of 1a and 4.0 equiv of TBAF in THF (entry 5), a high yield of the 
corresponding benzisoxazoline (92%) was obtained. These reaction conditions, however, 
turned out not to be suitable for other nitrones, probably again due to the relative rapid 
rate of benzyne generation. In order to better control the rate of benzyne generation, 
differing amounts of CsF in THF were examined, since CsF has limited solubility in THF, 
thus reducing the rate of benzyne generation (entries 6-9). Using 2.0 equiv of 1a and 5.0 
equiv of CsF at 65 oC in THF, a 93% yield of the desired cycloadduct was produced 
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(entry 7). Using reduced amounts of the benzyne precursor (1.6 equiv) and CsF (4.0 
equiv) still afforded a high 91% yield (entry 8).  
Table 1. Optimization studies of the reaction between o-(trimethylsilyl)phenyl triflate 
(1a) and N-benzylidenebenzylamine N-oxide (2a) a  
 
entry benzyne 
(equiv) 
CsF 
(equiv) 
solvent 
 
temp. 
(oC) 
time 
(h) 
% yield 
of 3ab 
1 1.2 3.0 MeCN rt 24 60 
2 1.2 4.0 MeCN rt 24 65 
3 2.0 3.0 MeCN rt 24 56 
4 1.2 2.0 TBAFc THF rt 24 45 
5 2.0 4.0 TBAFc THF 45 24 92 
6 1.2 3.0 THF 65 24 68 
7 2.0 5.0 THF 65 14 93 
8 1.6 4.0 THF 65 14 91 
9 1.6 3.0 THF 65 24 83 
aAll reactions were conducted on a 0.25 mmol scale in 5 ml of  solvent for 24 h. bYields   
of product isolated by column chromatography. c1M TBAF in THF solution. 
_______________________________________________________________________ 
 
Reaction Scope and Limitations      
    Using the optimal conditions shown in Table 1, entry 8, the scope and limitations of 
this methodology have been examined. Various substituted nitrones have been examined 
in this reaction (eq 1) and the results are summarized in Table 2.  
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Table 2. Cycloadditions of Benzyne with Nitrones a       
       
 
entry                nitrone                  yield (%)b      entry                  nitrone               yield (%)b 
 
 
1 
 
 
 
2a 
 
3a/91 
 
 
8 
 
 
 
2h 
 
 
3h/65 
2 
 
2b 
3b/88 
 
9 
 
 
2i 
3i/69 
3 
 
2c 
3c/95 10 
 
2j 
3j/92 
 
4 
 
 
2d 
3d/90 
 
11 
 
 
2k 
3k/90 
 
5 
N
O
+
_
 
2e 
 
3e/79 
 
 
12 
 
 
2l 
 
 
3l/93 
 
 
6 
 
 
 
2f 
3f/90 13 
2m 
3m/90 
 
 
7 
 
 
 
2g 
 
3g/79 
 
14 
 
 
2n 
 
 
3n/88 
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entry             nitrone                         yield (%)b       entry                  nitrone          yield (%)b 
15 
 
2o 
3o/77 20 
2t 
 
 
3t/64 
 
 
 
 
16 
 
 
 
2p 
 
3p/74 
 
21 
 
 
2u 
 
3u/65 
 
17 
 
 
2q 
 
3q/57 
 
22 
 
N
O
+
_
 
2v 
 
3v/60 
18 
 
2r 
3r/70 23 
 
N
O
+
_
 
2w 
3w/64 
19 
 
2s 
3s/56  
 
 
aUnless otherwise stated, all reactions have been carried out on a 0.25 mmol scale, with           
1.6 equiv of benzyne precursor 1a and 4.0 equiv of CsF in 5 ml of  THF at 65 oC for 14 h. 
b Yields of products  isolated by column chromatography.   
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Excellent yields have been obtained from both N-alkyl (entries 2-5) and N-benzyl-
substituted nitrones (entries 1, and 6-9). The results suggest that the steric effect of  
substituents on the carbon of the nitrone double bond  are significant. Lower yields are 
observed for the substrates with more steric hindrance on the carbon of the C-N double 
bond. For example, 2e, which has two methyls on the carbon of the C-N double bond 
(entry 5), and 2h, which has an ortho-methoxy-substituted phenyl on that carbon (entries 
8) both give lower yields. The process has also been applied to N-aryl-substituted nitrone 
2j (entry 10), which affords a high 92% yield of benzisoxazoline.  
     Nitrones with a variety of functionally-substituted phenyl groups on the nitrone carbon 
have been examined under our optimal conditions (entries 11-19). Many functional 
groups are well tolerated, including ester, cyano, amino, halogen and other groups. 
Nitrones with electron-donating groups tend to result in lower yields (entries 15 and 16) 
than nitrones with electron-withdrawing groups (entries 11-13), presumably due to the 
reduced electrophilicity of the carbon-nitrogen double bond due to the presence of such 
groups (see the later mechanistic discussion). Nitrone 2q also afforded a relatively low 
yield of 57%, mainly due to the steric hindrance produced by the ortho-methoxy group 
(entry 17). Due to the presence of the additional carbon-carbon double bond in 2s, the 
reaction was not as clean as that of other substrates, but still produced a good yield (entry 
19).12 Several cyclic nitrones have also been examined and moderate yields have been 
obtained (entries 21-23). 
   After a variety of substituted nitrones were examined, the behavior of various aryne 
precursors was examined in this reaction (Table 3). Dimethyl- (1b), dimethoxy- (1c) and 
difluoro-substituted (1d) benzyne precursors were employed under our optimal reaction 
conditions with nitrone 2f. All of these substrates generated comparable, but lower yields 
than benzyne itself. Similar results have been observed before in other reaction systems.6 
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Table 3. Investigation of Different Arynes in the Coupling Reaction with Nitrone 2f a       
 
entry      aryne product   yield (%)b 
1 
 
 
 
1b 
O
N Bn
OMe
Me
Me
 
(3fb) 72 
2 
 
 
 
1c 
 
(3fc) 70 
3 
 
 
 
1d 
O
N Bn
OMe
F
F
 
(3fd) 41 
a Unless otherwise stated, all reactions have been carried out on a 0.25 mmol scale 
with 1.6 equiv of aryne precursor and 4.0 equiv of CsF in 5 ml of  THF at 65 oC for 
14 h. b Yields of products  isolated by column chromatography. 
 
    Two possible mechanisms for this process are proposed in Scheme 1 based on the 
experimental results and previous experience.8 Following the formation of benzyne 
induced by fluoride from benzyne precursor 1a, a [3+2] cycloaddition can occur. 
Nucleophilic attack of the oxygen anion of 2a on benzyne, quickly followed by 
cyclization of 3a′, can be envisioned as a mechanistic alternative. The significant steric 
and electronic effects of the substituents on the carbon-nitrogen double bond of the 
nitrone on the reaction results are consistent with both of these proposed mechanisms. 
The steric hindrance arising from the substituent on the carbon of the C-N double bond 
(see the results of entries 5, 8 and 17 in Table 2) are expected to disfavor the 
cycloaddition of 2a to 3a or the cycloaddition of 3a’ to 3a. Furthermore, the presence of 
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electron-withdrawing substituents on the phenyl group present on the carbon of the C-N 
double bond (see the results of entries 12-16 in Table 2) would be expected to increase 
the electrophilicity of the C-N double bond in 3a’ producing higher yields.      
Scheme 1. Possible Mechanisms 
                  
.      
Conclusions 
 In conclusion, we have developed a facile and general method for the synthesis of 
substituted benzisoxazolines by the 1,3-dipolar cycloaddition of arynes and nitrones 
under mild reaction conditions, which provides excellent yields. A variety of functional 
groups are well tolerated in this process, allowing further synthesis of more complicated 
molecules.     
Experimental Section 
General 
   The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 and 100 MHz 
respectively. All melting points are uncorrected. High resolution mass spectra were 
recorded using EI at 70 eV. All reagents were used directly as obtained commercially 
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unless otherwise noted. All reactions were carried out in oven-dried glassware and 
monitored by thin layer chromatography (SiO2, hexanes or hexanes/EtOAc). THF was 
distilled over Na. The silylaryl triflate 1a, CsF, TBAF solution (1M in THF) and 
acetonitrile were purchased from Sigma-Aldrich Co. 4,5-Dimethyl-substituted silylaryl 
triflate 1b, 4,5-dimethoxy-substituted silylaryl triflate 1c and 4,5-difluoro-substituted 
silylaryl triflate 1d were prepared according to a previous literature procedure.13 
Non-commercially available compounds   
   Non-commercially available starting materials were prepared according to literature 
procedures.14  
  
(2-Methoxyphenylmethylene)benzylamine-N-oxide (2h): light yellow solid, mp 78-79 
°C; 1H NMR (300 MHz, CDCl3) δ 9.28 (dd, J = 7.8, 1.5 Hz, 1H), 7.96 (s, 1H), 7.51-7.26 
(m, 7H), 6.99 (t, J = 8.1 Hz, 1H), 6.85 (d, J = 7.5 Hz, 1H), 5.05 (s, 2H), 3.83 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 157.01, 133.87, 131.71, 129.10, 128.92, 128.83, 128.77, 
120.82, 119.65, 109.83, 71.72, 55.64; HRMS (EI) calcd for C15H15NO2: 241.1103, found 
241.1101.  
 
(3-Nitrophenylmethylene)benzylamine-N-oxide (2i):  yellow solid, mp 142-144 °C; 1H 
NMR (300 MHz, CDCl3) δ 9.04 (s, 1H), 8.57 (d, J = 7.8 Hz, 1H), 8.20 (d, J = 8.1 Hz, 
1H), 7.57-7.41 (m, 7H), 5.11 (s, 2H); 13C NMR (300 MHz, CDCl3) δ 148.24, 133.78, 
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132.75, 132.11, 131.95, 129.64, 129.52, 129.45, 129.24, 124.65, 123.11, 71.85; HRMS 
(EI) calcd for C14H12N2O3: 256.0848, found 256.0843.  
 
(5-Bromo-2-methoxyphenylmethylene)phenylamine-N-oxide (2q): yellow solid, mp 
135-137 °C;  1H NMR (300 MHz, CDCl3) δ 9.66 (d, J = 2.7 Hz, 1H), 8.33 (s, 1H), 7.78-
7.74 (m, 2H), 7.51-7.46 (m, 4H), 6.79 (d, J = 9.0 Hz, 1H), 3.86 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 156.54, 149.57, 134.61, 131.08, 130.11, 129.32, 128.15, 121.90, 121.65, 
113.59, 111.65, 56.08; HRMS (EI) calcd for C14H12NO2Br: 306.0041, found 306.0043.  
 
(4,5-Dimethoxy-3-iodophenylmethylene)phenylamine-N-oxide (2r): yellow solid, mp 
162-164 °C; 1H NMR (300 MHz, CDCl3) δ 8.60 (d, J = 1.5 Hz, 1H), 7.94 (d, J = 1.8 Hz, 
1H), 7.82 (s, 1H), 7.75-7.72 (m, 2H), 7.45 (m,, 3H), 3.92 (s, 3H), 3.89 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 152.21, 150.78, 148.86, 132.84, 132.30, 130.20, 129.33, 128.82, 
121.67, 112.47, 92.01, 60.72, 56.13; HRMS (EI) calcd for C15H14NO3I: 383.0018, found 
383.0014. 
 
2,6-Dimethyl-2,3,4,5-tetrahydropyridine-N-oxide (2v): yellow oil; 1H NMR (300 MHz, 
CDCl3) δ 3.68 (m, 1H), 2.25 (t, J = 6.0 Hz, 2H), 1.90-1.81 (m, 4H), 1.60-1.48 (m, 3H), 
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1.27 (dd, J = 9.0, 3.0 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 146.95, 61.85, 30.72, 
29.40, 18.88, 18.72, 15.20; HRMS (EI) calcd for C7H13ON: 127.0997, found 127.0991. 
Representative procedure for the cycloaddition of arynes and nitrones 
An oven dried 6-dram vial equipped with a stir bar was charged with 0.25 mmol of the 
nitrone, 1.6 equiv of the aryne precursor and 4.0 equiv of CsF, followed by 5 ml of dry 
THF. The vial was sealed and placed in an oil bath at 65 °C for about 14 h. The resultant 
mixture was cooled and concentrated under vacuum to yield the crude product, which was 
purified by flash chromatography on silica gel with ethyl acetate/hexanes or 
dichloromethane/hexane as the eluent. 
 
2-Butyl-3-phenyl-2,3-dihydrobenzo[d]isoxazole (3b): colorless oil; 1H NMR (300 
MHz, CDCl3) δ 7.45-7.33 (m, 5H), 7.22 (t, J = 6.0 Hz, 1H), 7.00 (d, J = 6.0 Hz, 1H), 
6.93-6.87 (m, 2H), 3.27 (m, 1H), 3.01 (m, 1H), 1.78-1.71 (m, 2H), 1.51-1.38 (m, 2H), 
0.95 (t, J = 6.0 Hz, 3H),; 13C NMR (300 MHz, CDCl3) δ 156.06, 140.82, 129.54, 128.94, 
128.13, 127.99, 124.11, 121.33, 107.97, 74.47, 59.59, 29.95, 20.63, 14.11; HRMS (EI) 
calcd for C17H19NO: 253.1467, found 253.1463.  
 
2-tert-Butyl-3-phenyl-2,3-dihydrobenzo[d]isoxazole (3c): white solid, mp 94-96 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.43-7.26 (m, 5H), 7.14 (d, J = 9.0 Hz, 1H), 6.90 (d, J = 6.0 
Hz, 1H), 6.83-6.79 (m, 2H), 5.61 (s, 1H), 1.20 (s, 9H); 13C NMR (300 MHz, CDCl3) δ 
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156.35, 144.09, 130.04, 128.79, 127.57, 127.54, 123.80, 120.86, 106.93, 67.18, 61.20, 
29.92, 25.69; HRMS (EI) calcd for C17H19NO: 253.1467, found 253.1468.  
 
2-Isopropyl-3,3-dimethyl-2,3-dihydrobenzo[d]isoxazole (3e): light brown oil; 1H NMR 
(300 MHz, CDCl3) δ 7.21-7.15 (m, 2H), 6.92 (t, J = 6.0 Hz, 1H), 6.81 (d, J = 9.0 Hz, 1H), 
4.05 (t, J = 6.0 Hz, 1H), 3.03 (m, 1H), 2.68 (m, 1H), 1.71 (m, 4H), 1.01 (td, J = 9.0, 6.0 
Hz, 6H); 13C NMR (300 MHz, CDCl3) δ 156.25, 128.96, 128.65, 123.89, 121.09, 108.32, 
71.22, 62.30, 29.47, 21.00, 11.95, 10.25; HRMS (EI) calcd for C12H17NO: 191.1310, 
found 191.1308. 
 
2-Benzyl-3-(4-methoxyphenyl)-2,3-dihydrobenzo[d]isoxazole (3f): white solid, mp 
121-123 °C; 1H NMR (300 MHz, CDCl3) δ 7.46-7.31 (m, 5H), 7.26-7.20 (m, 3H), 7.02 (d, 
J = 6.0 Hz, 1H), 6.95-6.86 (m, 4H), 5.34 (s, 1H), 4.38 (d, J = 12.0 Hz, 1H), 4.18 (d, J = 
12.0 Hz, 1H), 3.81 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 159.55, 156.35, 136.64, 
132.55, 129.45, 129.24, 129.22, 128.99, 128.61, 127.80, 124.33, 121.55, 114.17, 108.27, 
72.48, 62.62, 55.45; HRMS (EI) calcd for C21H19NO2: 317.1416, found 317.1420.  
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2-Benzyl-3-(3-methoxyphenyl)-2,3-dihydrobenzo[d]isoxazole (3g): white solid, mp 69-
72 °C; 1H NMR (300 MHz, CDCl3) δ 7.46 (d, J = 6.0 Hz, 2H), 7.41-7.32 (m, 3H), 7.83 
(m, 2H), 7.29-7.21 (m, 2H), 7.07 (d, J = 6.0 Hz, 1H), 6.96-6.83 (m, 5H), 5.36 (s, 3H), 
4.42 (d, J = 12.0 Hz, 1H), 4.18 (d, J = 12.0 Hz, 1H), 3.77 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 159.98, 156.25, 142.17, 136.49, 129.76, 129.50, 129.11, 128.75, 128.63, 
127.86, 124.40, 121.60, 120.17, 113.75, 113.29, 108.33, 72.68, 62.91, 55.37; HRMS (EI) 
calcd for C21H19NO2: 317.1416, found 317.1422.  
 
2-Benzyl-3-(2-methoxyphenyl)-2,3-dihydrobenzo[d]isoxazole (3h): white solid, mp 71-
73 °C; 1H NMR (300 MHz, CDCl3) δ 7.46 (d, J = 6.0 Hz, 2H), 7.38-7.19 (m, 8H), 6.95-
6.86 (m, 4H), 5.89 (s, 1H), 4.37 (d, J = 15.0 Hz, 1H), 4.18 (d, J = 15.0 Hz, 1H), 3.84 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 156.69, 156.41, 137.09, 129.58, 129.44, 128.88, 
128.85, 128.48, 127.61, 124.82, 121.60, 121.05, 110.40, 108.48, 66.35, 63.47, 55.49; 
HRMS (EI) calcd for C21H19NO2: 317.1416, found 317.1419.  
 
2-Benzyl-3-(3-nitrophenyl)-2,3-dihydrobenzo[d]isoxazole (3i): white solid, mp 118-
120 °C; 1H NMR (300 MHz, CDCl3) δ 8.11 (dd, J = 6.0, 3.0 Hz, 2H), 7.62 (d, J = 6.0 Hz, 
2H), 7.49-7.25 (m, 8H), 7.09 (d, J = 9.0 Hz, 1H), 6.97 (d, J = 9.0 Hz, 1H), 6.91 (d, J = 9.0 
Hz, 1H), 5.44 (s, 1H), 4.50 (d, J = 12.0 Hz, 1H), 4.13 (d, J = 12.0 Hz, 1H); 13C NMR (300 
MHz, CDCl3) δ 156.23, 148.08, 143.29, 135.67, 133.73, 129.82, 129.76, 129.56, 128.80, 
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128.21, 127.28, 124.39, 123.00, 122.62, 122.08, 108.81, 71.46, 63.20; HRMS (EI) calcd 
for C20H16N2O3: 332.1161, found 332.1166.  
 
2,3-Diphenyl-2,3-dihydrobenzo[d]isoxazole (3j): light brown oil; 1H NMR (300 MHz, 
CDCl3) δ 7.19-7.15 (m, 2H), 7.09-6.85 (m, 7H), 6.74 (d, J = 9.0 Hz, 2H), 6.62 (t, J = 6.0 
Hz, 1H), 6.53-6.49 (m, 1H), 6.43 (dd, J = 6.0, 3.0 Hz, 2H); 13C NMR (300 MHz, CDCl3) 
δ 150.59, 138.58, 136.46, 131.45, 129.91, 129.54, 129.08, 127.67, 127.24, 122.82, 
121.11, 118.32, 110.22, 108.89, 99.28; HRMS (EI) calcd for C19H15NO: 273.1154, found 
273.1152.  
 
3-(2-Chlorophenyl)-2-phenyl-2,3-dihydrobenzo[d]isoxazole (3k): white solid, mp 74-
76 °C; 1H NMR (300 MHz, CDCl3) δ 7.54 (d, J = 6.0 Hz, 1H), 7.44 (d, J = 9.0 Hz, 1H), 
7.29-7.15 (m, 5H), 7.08 (dt, J = 9.0, 3.0 Hz, 2H), 6.99 (t, J = 9.0 Hz, 1H), 6.92-6.87 (m, 
1H), 6.82-6.79 (m, 2H); 13C NMR (300 MHz, CDCl3) δ 150.34, 142.32, 135.31, 134.38, 
133.46, 130.98, 130.33, 129.63, 128.79, 127.61, 122.66, 121.41, 121.30, 117.47, 110.48, 
109.23, 95.58; HRMS (EI) calcd for C19H14NOCl: 307.0764, found 307.0769.  
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 2-Phenyl-3-(4-trifluoromethylphenyl)-2,3-dihydrobenzo[d]isoxazole (3l): white solid, 
mp 86-88 °C; 1H NMR (300 MHz, CDCl3) δ 7.66 (t, J = 9.6 Hz, 4H), 7.32-7.24 (m, 2H), 
7.13-7.01 (m, 4H), 6.94-6.79 (m, 4H); 13C NMR (300 MHz, CDCl3) δ 150.38, 142.61, 
142.41, 134.60, 129.75, 127.68, 126.21, 126.15, 126.10, 126.06, 123.28, 121.57, 118.38, 
110.81, 109.11, 98.38; HRMS (EI) calcd for C20H14NOF3: 341.1027, found 341.1032.  
 
3-(4-Carbomethoxyphenyl)-2-phenyl-2,3-dihydrobenzo[d]isoxazole (3m): white solid, 
mp 118-120 °C; 1H NMR (300 MHz, CDCl3) δ 8.06 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.1 
Hz, 2H), 7.27 (t, J = 7.5 Hz, 2H), 7.10 (m, 3H), 7.02 (t, J = 7.5 Hz, 1H) , 6.92-6.79 (m, 
4H), 3.90 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.75, 150.46, 143.14, 142.49, 134.69, 
131.54, 130.38, 129.66, 127.31, 123.17, 121.47, 121.37, 118.47, 110.54, 109.01, 98.62, 
52.44; HRMS (EI) calcd for C21H17NO3: 331.1208, found 331.1215.  
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3-(4-Cyanophenyl)-2-phenyl-2,3-dihydrobenzo[d]isoxazole (3n): white solid, mp 105-
108 °C; 1H NMR (300 MHz, CDCl3) δ 7.72-7.65 (m, 4H), 7.30 (t, J = 7.5 Hz, 2H), 7.12-
7.03 (m, 4H), 6.94-6.79 (m, 4H); 13C NMR (300 MHz, CDCl3) δ 150.28, 143.47, 132.96, 
129.81, 128.00, 123.49, 121.74, 121.71, 118.56, 118.46, 113.73, 111.01, 109.19, 98.17; 
HRMS (EI) calcd for C20H14N2O: 298.1106, found 298.1106.  
 
3-(4-Methylthiophenyl)-2-phenyl-2,3-dihydrobenzo[d]isoxazole (3o): white solid, mp 
82-84 °C; 1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 9.0 Hz, 2H), 7.29-7.23 (m, 4H), 
7.12-7.08 (m, 3H), 7.00 (t, J = 9.0 Hz, 1H), 6.90-6.83 (m, 1H) , 6.80-6.76 (m, 3H), 2.46 
(s, 3H); 13C NMR (300 MHz, CDCl3) δ 150.52, 142.45, 140.82, 135.18, 130.15, 129.57, 
127.74, 126.65, 122.81, 121.24, 121.10, 118.44, 110.10, 108.88, 98.94, 15.65; HRMS 
(EI) calcd for C20H17NOS: 319.1031, found 319.1034.  
 
3-[4-(Dimethylamino)phenyl]-2-phenyl-2,3-dihydrobenzo[d]isoxazole (3p): light 
brown oil; 1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 8.7 Hz, 2H), 7.29-7.20 (m, 3H), 
7.16-7.08 (m, 3H), 6.98 (t, J = 7.2 Hz, 1H), 6.86 (td, J = 6.0, 3.0 Hz, 1H), 6.79-6.77 (m, 
2H) , 6.70 (d, J = 9.0 Hz, 2H), 2.96 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 151.65, 
150.67, 142.52, 129.63, 129.43, 128.35, 125.81, 122.51, 120.89, 120.72, 118.43, 112.42, 
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109.58, 108.72, 99.57, 40.59; HRMS (EI) calcd for C21H20ON2: 316.1576, found 
316.1583. 
 
3-(5-Bromo-2-methoxyphenyl)-2-phenyl-2,3-dihydrobenzo[d]isoxazole (3q): white 
solid, mp 73-75 °C; 1H NMR (300 MHz, CDCl3) δ 7.55 (d, J = 3.0 Hz, 1H), 7.43 (dd, J = 
6.0, 3.0 Hz, 1H), 7.27 (t, J = 6.0 Hz, 2H), 7.19-7.16 (m, 2H), 7.11-7.08 (dd, J = 9.0, 3.0 
Hz, 2H), 7.00 (t, J = 9.0 Hz, 1H) , 6.90 (td, J = 6.0, 3.0 Hz, 1H), 6.85 (s, 1H), 6.80 (dd, J 
= 9.0, 3.0 Hz, 2H), 3.89 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 156.66, 150.47, 142.79, 
134.25, 133.74, 130.80, 129.56, 128.43, 122.59, 121.44, 121.22, 117.43, 113.54, 113.16, 
110.99, 109.14, 93.43, 56.25; HRMS (EI) calcd for C20H16NO2Br: 381.0364, found 
381.0368.  
 
3-(4,5-Dimethoxy-3-iodophenyl)-2-phenyl-2,3-dihydrobenzo[d]isoxazole (3r): light 
brown oil; 1H NMR (300 MHz, CDCl3) δ 7.55 (d, J = 3.0 Hz, 1H), 7.33 (d, J = 6.0 Hz, 
2H), 7.16-7.05 (m, 6H), 6.93 (td, J = 9.0, 6.0 Hz, 1H), 6.83 (t, J = 6.0 Hz, 2H), 6.70 (s, 
1H), 3.85 (s, 3H), 3.83 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 153.20, 150.29, 150.20, 
142.60, 136.30, 134.78, 129.68, 129.46, 123.31, 121.40, 118.63, 111.36, 110.61, 109.00, 
98.37, 92.87, 60.60, 56.24; HRMS (EI) calcd for C21H18NO3I: 459.0331, found 459.0320.  
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2-Phenyl-3-(E-2-phenylethenyl)-2,3-dihydrobenzo[d]isoxazole (3s): light brown oil; 
1H NMR (300 MHz, CDCl3); δ 7.48-7.43 (m, 3H), 7.38-7.28 (m, 6H), 7.09-7.05 (m, 2H), 
6.92-6.72 (m, 4H), 6.48-6.38 (m, 2H); 13C NMR (300 MHz, CDCl3) δ 150.85, 142.79, 
135.28, 131.49, 129.60, 129.31, 128.84, 128.70, 127.32, 125.38, 122.93, 121.18, 121.06, 
118.49, 110.80, 108.91, 99.10; HRMS (EI) calcd for C21H17ON: 299.0383, found 
299.1375. 
 
2-(4-Methoxyphenyl)-3-phenyl-2,3-dihydrobenzo[d]isoxazole (3t): white solid, mp 
118-120 °C; 1H NMR (300 MHz, CDCl3) δ 7.53 (dd, J = 6.0, 3.0 Hz, 2H), 7.36 (t, J = 3.0 
Hz, 1H), 7.03 (d, J = 9.0 Hz, 2H), 6.82-6.74 (m, 6H), 6.64 (s, 1H), 3.71 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 156.35, 150.43, 138.57, 136.91, 135.60, 129.89, 128.88, 127.59, 
122.56, 121.34, 120.32, 114.83, 108.90, 108.42, 100.51, 55.56; HRMS (EI) calcd for 
C20H17NO2: 303.1259, found 303.1255.  
 
5,12-Dihydro-6H-[1,2]benzisoxazolo[3,2]isoquinoline (3u): white solid, mp 69-72 °C; 
1H NMR (300 MHz, CDCl3) δ 7.37 (d, J = 9.0 Hz, 1H), 7.29 (t, J = 9.0 Hz, 1H), 7.22-
7.09 (m, 4H), 6.90-6.83 (m, 2H), 5.80 (s, 1H), 3.36-3.30 (m, 2H), 3.00-2.77 (m, 2H); 13C 
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NMR (300 MHz, CDCl3) δ 156.65, 134.11, 133.54, 129.09, 128.78, 128.62, 127.23, 
127.04, 126.87, 123.63, 121.62, 108.71, 65.66, 49.92, 26.85; HRMS (EI) calcd for 
C15H13NO: 2233.0997, found 223.1003.  
N
O
 
7,10a-Dimethylpyrido-8,9,10-trihydro[1,2]benzisoxazole (3v): colorless oil; 1H NMR 
(300 MHz, CDCl3) δ 7.13 (t, J = 6.0 Hz, 1H), 7.03 (d, J = 9.0 Hz, 1H), 6.87 (t, J = 6.0 Hz, 
1H), 6.78 (d, J = 9.0 Hz, 1H), 3.22 (m, 1H), 1.63-1.51 (m, 9H), 1.41 (d, J = 9.0 Hz, 3H); 
13C NMR (300 MHz, CDCl3) δ 155.52, 136.89, 128.00, 120.97, 120.75, 107.98, 65.55, 
53.97, 33.34, 26.31, 22.81, 20.30, 19.34; HRMS (EI) calcd for C13H17NO: 203.1310, 
found 203.1306.  
N
O
 
10a-Methyl-7,8,9,10-tetrahydropyrido[1,2]benzisoxazole (3w): colorless oil; 1H NMR 
(300 MHz, CDCl3) δ 7.19 (d, J = 9.0 Hz, 1H), 7.07 (d, J = 6.0 Hz, 1H), 6.97 (t, J = 6.0 
Hz, 1H), 6.89 (d, J = 9.0 Hz, 1H), 3.39 (m, 1H), 2.64 (td, J = 9.0, 6.0 Hz, 1H), 2.29 (m, 
1H), 1.86 (m, 1H), 1.65-1.51 (m, 3H), 1.35 (s, 3H), 1.35-1.23 (m, 3H); 13C NMR (300 
MHz, CDCl3) δ 157.22, 133.39, 128.21, 121.77, 121.70, 109.94, 67.00, 52.73, 32.81, 
30.01, 23.48, 20.48; HRMS (EI) calcd for C12H15NO: 189.1154, found 189.1149.  
O
N Bn
OMe
Me
Me
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2-Benzyl-3-(4-methoxyphenyl)-2,3-dihydro-5,6-dimethylbenzo[d]isoxazole (3fb): 
yellow solid, mp 121-123 °C; 1H NMR (300 MHz, CDCl3) δ 7.43-7.26 (m, 5H), 7.18 (d, J 
= 8.4 Hz, 2H), 6.85 (d, J = 9.0 Hz, 2H), 6.78 (s, 1H), 6.68 (s, 1H), 5.25 (s, 1H) , 4.35 (d, J 
= 13.0 Hz, 1H), 4.12 (d, J = 13.0 Hz, 1H), 3.79 (s, 3H), 2.25 (s, 3H), 2.17 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 159.46, 154.75, 137.50, 136.81, 133.17, 129.71, 129.57, 
129.51, 129.14, 128.59, 127.74, 126.46, 125.10, 114.14, 109.33, 72.33, 62.75, 55.46, 
20.46, 19.55; HRMS (EI) calcd for C23H23NO2: 345.1729, found 345.1721.  
 
2-Benzyl-5,6-dimethoxy-3-(4-methoxyphenyl)-2,3-dihydrobenzo[d]isoxazole (3fc): 
light brown oil; 1H NMR (300 MHz, CDCl3) δ 7.42-7.27 (m, 5H), 7.16 (d, J = 9.0 Hz, 
2H), 6.86 (d, J = 9.0 Hz, 2H), 6.53 (d, J = 9.0 Hz, 2H), 5.27 (s, 1H), 4.35 (d, J = 12.0 Hz, 
1H), 4.14 (d, J = 15.0 Hz, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 3.77 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 159.61, 150.76, 150.25, 144.46, 136.77, 132.82, 129.48, 129.35, 128.62, 
127.80, 118.67, 114.22, 107.91, 93.55, 73.01, 62.76, 56.98, 56.35, 55.50; HRMS (EI) 
calcd for C23H23NO4: 377.1627, found 377.1620.  
O
N Bn
OMe
F
F
 
2-Benzyl-5,6-difluoro-3-(4-methoxyphenyl)-2,3-dihydrobenzo[d]isoxazole (3fd): light 
brown oil; 1H NMR (300 MHz, CDCl3) δ 7.40-7.31 (m, 6H), 7.20 (d, J = 9.0 Hz, 2H), 
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6.89 (d, J = 9.0 Hz, 2H), 6.77 (t, J = 9.0 Hz, 1H), 6.66 (dd, J = 9.0, 6.0 Hz, 1H), 5.27 (s, 
1H) , 4.34 (d, J = 12.0 Hz, 1H), 4.16 (d, J = 12.0 Hz, 1H), 3.82 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 159.91, 136.17, 129.41, 129.34, 128.70, 128.02, 114.40, 112.70, 112.43, 
98.29, 97.98, 72.48, 62.54, 55.52; HRMS (EI) calcd for C21H17NO2F2: 353.1227, found 
353.1230.  
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CHAPTER 3. Palladium-Catalyzed Annulation 
of Arynes by ortho-Halobenzamides: Synthesis of Phenanthridinones 
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Abstract 
    The palladium-catalyzed annulation of arynes by substituted o-halobenzamides 
produces N-substituted phenanthridinones in good yields. This methodology provides this 
important heterocyclic ring system in a single step by simultaneous C-C and C-N bond 
formation, under relatively mild reaction conditions, and tolerates a variety of functional 
groups.  
Introduction  
    Phenanthridinones are important sub-units found in many compounds possessing 
interesting biological and pharmaceutical activities. They have been used as PARP 
inhibitor anticancer drugs,1 and as neurotrophin activity enhancers for the treatment of 
nerve diseases.2 The most widely accepted approach for the synthesis of 
phenanthridinones is through the reductive cyclization of corresponding nitro-carbonyl-
biphenyls.3 However, traditional preparations of the starting nitro-carbonyl-biaryls, by 
Ullmann-coupling reactions or the nitration of biaryls,4 require either harsh reaction 
conditions or exotic functionalized arenes, significantly limiting the broad application of 
this approach. 
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    Transition metal-catalyzed annulation reactions are tremendously valuable in organic 
synthesis.5 Among such processes, palladium-mediated reactions are by far the most 
powerful in constructing carbocycles and heterocycles,6  due to the high efficiency with 
which they construct C-C and C-X (X = O, N) bonds7 and their high compatibility with 
functional groups. For example, some phenanthridinone derivatives have been synthesized 
by palladium-catalyzed intramolecular or intermolecular cyclization processes of aryl 
halides and amides.8 
    Since a convenient approach to aryne generation by the fluoride-induced 1,2-
elimination of o-(trimethylsilyl)aryl triflates was first reported,9 arynes have attracted 
considerable attention.10 The high electrophilicity of arynes has been used extensively in 
the construction of many heteroaromatic structures via either simple nucleophilic 
reactions11 or annulation reactions.12 To take further advantage of aryne chemistry, many 
metal-catalyzed coupling13 and annulation reactions14 of arynes have been explored. In 
our group, we are especially interested in the palladium-catalyzed annulation of arynes.15 
    Herein, we report the palladium-catalyzed annulation of arynes by substituted o-
halobenzamides to produce N-substituted phenanthridinones in good yields. In this 
reaction, C-C and C-N bonds are formed simultaneously to generate this important 
heterocyclic ring system.   
Results and Discussion 
Optimization Studies   
    We attempted to optimize the reaction of N-ethyl-2-bromobenzamide (1a) and the 
benzyne precursor o-(trimethylsilyl)phenyl trifluoromethanesulfonate (2a) in 4:1 
toluene/acetonitrile with CsF as the fluoride source (Table 1). In all of the cases, there  
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Table 1. Optimization of the Pd-Catalyzed Annulation of Benzyne (eq 1)a 
 
 entry           ligand                         additive                         solvent                          % yield  
                   (mol %)                        (equiv)                     (toluene/MeCN)                 of 3ab  
1 -------- -------- 4:1 10 
2 PPh3  (10) -------- 4:1 13 
3 P(o-tolyl)3  (10) -------- 4:1 50 
4 dppm (10) -------- 4:1 66 
5 dppe  (10) -------- 4:1 30 
6 dppf  (10) -------- 4:1 25 
7 L  (10)c -------- 4:1 56 
8 dppm  (5) -------- 4:1 53 
9 dppm  (10) Na2CO3 (1) 4:1 73 
10 dppm  (10) K2CO3 (1) 4:1 70 
11 dppm  (10) Cs2CO3 (1) 4:1 67 
12 dppm  (10) Na2CO3 (2) 4:1 57 
13 dppm  (10) Na2CO3 (1) 3:1 52 
14 dppm  (10) Na2CO3 (1) 6:1 49 
15 dppm  (10) Na2CO3 (1) 4:1 50d 
16 dppm  (10) Na2CO3 (1) 4:1 60e 
aAll reactions were run using substrate 1a (0.25 mmol), 5 mol % of  Pd(OAc)2, 2.0 equiv of 
2a, 5.0 equiv of  CsF, 5 ml of solvent at 110 °C for 16-24 h, unless otherwise specified.  
b Isolated yield. c See L in equation 1. d The reaction was conducted at 90 °C for 12 h, at 
which time the Pd had precipitated out. e 1.6 Equiv of 2a and 4.0 equiv of  CsF were 
employed. 
49 
 
was side product 4a produced by the cyclotrimerization of benzyne,15 plus the desired 
benzyne annulation product 3a (eq 1) . 
    Optimization work was conducted with respect to different palladium catalysts, 
ligands, solvents and temperatures and the results are shown in Table 1. Without any 
ligand, palladium black precipitated out very quickly with only a trace amount of the 
desired product formed and the aryl halide 1a was left in large amounts (entry 1). Simple 
triphenylphosphine ligand did not improve the yield (entry 2). Both tri(o-tolyl)phosphine 
and the biarylphosphine ligand L (eq 1) increased the yield to around 50% (entries 3 and 
7). Several bidentate ligands have also been examined (entries 4-6). Among them, dppm 
proved the most efficient, producing lactam 3a in a 66% yield, although 10 mol % of 
ligand seemed necessary to maintain a decent yield (entry 8). Besides examining the 
effect on the yield of the ligand, several bases have also been tested in this reaction 
(entries 9-12). The results indicate that with 1.0 equiv of Na2CO3, a 73% yield of the 
desired product can be achieved  (entry 9). Other bases gave lower yields. Based on our 
previous experience, the solvent can often prove critical for palladium-catalyzed benzyne 
reactions,  mostly because the benzyne is generated at vastly different rates in different 
solvents.14 With a toluene/acetonitrile mixed solvent and CsF as the fluoride source, 
benzyne is generated more slowly in mixtures with less acetonitrile, because CsF has a 
lower solubility in toluene. Thus, the solvent ratio was examined and 4:1 
toluene/acetonitrile afforded the best result (compare entries 9, 13 and 14). With a 3:1 
ratio, more side product, trimer 4a, is formed; with a 6:1 ratio, the benzyne is generated 
too slowly, giving a lower yield.  
An effort was also made to lower the temperature and the benzyne precursor loading 
(entries 15 and 16), but it appears that 110 oC and 2 equiv of the benzyne precursor plus 5 
equiv of CsF are necessary in order to obtain a high yield. Several other palladium 
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catalysts, including PdCl2(MeCN)2 (63%), Pd(dba)2 (65%) and Pd(PPh3)4 (61%), have 
also been examined in this process; but none proved better than Pd(OAc)2. In the end, we 
have chosen the reaction conditions reported in entry 9 of Table 1 as our optimal 
conditions. 
Reaction Scope and Limitations 
To further test the scope and limitations of this reaction, we have examined a variety of 
substituted 2- halobenzamides and the results are summarized in Table 2. Different amide 
nitrogen substituents, including alkyl (entries 1-4), allyl (entry 5), phenyl (entry 6) and 
benzyl groups (entries 7-10), have been examined. Among them, excellent yields were 
achieved for N-primary and secondary alkyl (entries 1-3) substituted amides, as well as N-
benzyl substituted amides (entries 7-10). The analogous amide with an N-t-Bu (entry 4) 
afforded a lower yield presumably due to the steric hindrance of the t-Bu group. The 
presence of an N-allyl group (entry 5) also caused complications and the reaction looked 
messier on the TLC plate than the parent system (1a) with a resulting lower yield. Aryl-
substituted amide 1f produced some uncharacterized products which overlapped with the 
starting material amide left on the TLC plate (entry 6). The reaction was also performed 
using 2-iodobenzamide 1k (entry 11) and a much lower yield was obtained than the 
corresponding bromobenzamide 1g. Although for most palladium-catalyzed reactions of 
aryl halides, aryl iodides provide better results than the corresponding aryl bromides 
because the oxidative addition of Pd(0) to the aryl halide is easier and faster (see the later 
mechanistic discussion), there are several publications where the same halide effect as 
seen here has been reported and mechanistic studies on such reactions have been 
conducted.17 The reason for this halogen effect is not clear. However, we have observed 
that palladium precipitates out more quickly with a lower conversion and more side 
products in the reaction of 1k than in the reaction of 1g.  
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Table 2.  Pd-Catalyzed Annulation of Benzyne 2aa         
 
entry substrate % yield 
of 3b 
entry substrate % yield 
of 3b 
 
 
1 
 
 
(1a) 
 
 
(3a) 73 
 
 
7 
 
 
 
(1g) 
 
 
(3g) 82 
 
 
2 
 
 
 
(1b) 
 
 
(3b) 70 
 
 
8 
 
 
 
(1h) 
 
 
 
(3h) 77 
 
 
3 
 
 
(1c) 
 
 
 
(3c) 87 
 
 
9 
 
 
 
(1i) 
 
 
(3i) 75 
 
 
4 
 
 
 
(1d) 
 
 
 
(3d) 64 
 
 
10 
 
 
 
(1j) 
 
 
(3j) 83 
 
 
5 
 
 
 
(1e) 
 
 
(3e) 65 
 
 
11 
 
 
 
(1k) 
 
 
(3k) 38 
 
 
6 
 
 
 
(1f) 
 
 
(3f) --c 
 
 
12 
 
 
(1l) 
 
 
(3l) 84 
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entry substrate % yield 
of 3b 
entry substrate % yield 
of 3b 
 
 
13 
 
 
(1m) 
 
 
(3m) 79 
 
 
20 
 
 
(1t) 
 
 
(3t) 79 
 
 
14 
 
Br
O
N
H
Bn
Me
 
(1n) 
 
 
(3n) 74 
 
 
21 
 
(1u) 
 
 
(3u) 70 
 
 
15 
 
 
(1o) 
 
 
(3o) 74 
 
 
22 
 
(1v) 
 
 
(3v) 55 
 
 
16 
 
 
 
 
(1p) 
 
 
(3p) 70 
 
 
23 
 
 
(1w) 
 
 
(3w) 36 
 
 
17 
 
 
(1q) 
 
 
(3q) 67 
 
 
24 
 
 
(1x) 
 
 
(3x) 0 
 
 
18 
 
 
(1r) 
 
 
(3r) 52 
 
 
25 
 
 
(1y) 
 
 
(3y) 0 
 
 
19 
 
 
(1s) 
 
 
(3s) 65 
  
 
a Representative procedure: 1 (0.25 mmol), 2.0 equiv of 2, 5.0 equiv of CsF, 5 mol % 
Pd(OAc)2, 10 mol % dppm, 1.0 equiv of Na2CO3 in 5 ml of 4:1 toluene/MeCN at 110 
oC for 16-24 h. b Isolated yield. cAn unknown mixture were generated whose products 
overlapped with the starting material 1d on the TLC plate. 
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To further test the scope and the limitations of the reaction, we examined a variety of  
2-bromobenzamides with various functional groups (entries 12-22). Amides with slightly 
electron-donating methyl groups at the 3 (entry 14), 4 (entry 12), and 5 (entry 13) 
positions generally afforded excellent yields of above 70%, although 1n provided a 
slightly lower yield than the others presumably due mainly to the steric hindrance of the 
methyl group during oxidative addition of the carbon-halogen bond to the palladium 
catalyst. Strong electron-donating methoxy groups also did not lower the yield 
significantly and yields above 70% were generated from 1o and 1p, which suggested that 
the oxidative addition of the aryl bromide to Pd(0) is not very difficult under these 
reaction conditions. Halogens, such as F (entries 19 and 20) and Cl (entry 17), were well 
tolerated in these reactions, providing good yields of the corresponding amides.  
o-Bromobenzamides with electron-withdrawing groups, including CF3, NO2 and an 
amide group, were also tested and lower yields were obtained when compared to 1g. The 
reason for this decrease can be explained as follows. Although the electron-withdrawing 
nature of these functional groups facilitates oxidative addition of the carbon-bromine 
bond in the amide to Pd(0), it at the same time decreases the nucleophilic nature of the 
nitrogen in the amide, which is critical for the cyclization step (see the later mechanistic 
discussion).  
In addition to these N-benzyl-2-bromobenzamide derivatives, the pyridine-derived 
amide 1w has also been examined, but only a 36% yield of the desired product was 
isolated, which may be caused by deactivation of the Pd catalyst through strong 
coordination of the nitrogen in the pyridine to Pd.  
    This reaction was also applied to 2-bromobenzamide (1w, entry 24) and N,N-dimethyl-
2-bromobenzamide (1y, entry 25). Both 1w and 1y remained in the reaction system in 
very large amounts after the reaction and neither of the desired products was observed. 
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The reason for the failure of these two reactions may not, however, be the same. In the 
reaction of 1w, strong coordination of the NH2 group with the Pd in either complex III or 
IV (see Scheme 1) may inhibit the cyclization; while, in 1y, two methyl groups on the 
nitrogen prohibit nucleophilic attack of the nitrogen on the Pd in complex III (see the step 
from III to V in Scheme 1).    
In addition to phenyl triflate 2a, other aryne precursors have also been examined in our 
methodology as an annulation partner (Table 3). 4,5-Dimethylbenzyne precursor 2b, 4,5-
dimethoxybenzyne precursor 2c and 4,5-difluorobenzyne precursor 2d have all been  
Table 3. Investigation of Different Arynes in the Pd-Catalyzed Annulation of o-   
               Halobenzamide 1g a  
 
entry aryne % yield of 3b 
 
 
1 
 
 
2b 
 
 
(3gb) 50 
 
 
2 
 
MeO
MeO TMS
OTf
 
 
2c 
 
(3gc) 46 
3 
 
2d 
 
(3gd) 43 
 
a
 Representative procedure: 1g (0.25 mmol), 2.0 equiv of 2, 5.0 equiv of CsF, 5 mol % 
Pd(OAc)2, 10 mol % dppm, 1.0 equiv of Na2CO3 in 5 ml of 4:1 toluene/MeCN at 110 oC 
for 16-24 h. b Isolated yield. 
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examined under our annulation conditions. They formed the expected annulation products  
3gb, 3gc and 3gd respectively, not surprisingly, with lower yields compared to benzyne 
precursor 2a (Table 2, entries 1-3). This may be due to either the slower rate of generation 
of the arynes or the lack of stability of these arynes, as has been suggested by earlier work 
in our group.18 
Based on our experimental results and previous experience with related processes,15 we 
propose that this phenanthridinone synthesis proceeds through either of the possible 
pathways shown in Scheme 1.  
Scheme 1. Tentative Mechanisms 
TMS
OTf
Pd
Pd
O
NHEt
Br
O
NHEt
PdBr
PdBr
O
NHEt
Pd(0)
Pd L
O
NEt
1a
path b
IV
III
V
I
II
2a
1a
path a
3a
CsF
TMSF, CsOTf
 
One possible pathway proceeds by the oxidative cyclization of Pd(0) with the aryne 
generated from the silyl triflate to form palladacycle I (path a).19  Oxidative addition of 1a 
to this palladacycle forms Pd(IV) intermediate II. Reductive elimination gives rise to 
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arylpalladium(II) intermediate III. However, we cannot rule out the possibility that Pd(0) 
inserts directly into the C-Br bond of 1a to form intermediate IV, which then undergoes 
carbopalladation of the aryne to give rise to intermediate III20 (path b). Regardless of how 
intermediate III is formed, under the basic conditions, it is expected to cyclize to 
intermediate V. Finally, through reductive elimination the desired product can be 
generated, alongside Pd(0), which can reenter the catalytic cycle. However, there does not 
appear to be any particular evidence favoring either of these pathways. 
Conclusions 
In summary, we have developed a novel synthesis of phenanthridinones, which 
involves the palladium-catalyzed annulation of arynes by 2-halobenzamides. This method 
provides an efficient synthesis of substituted phenanthridinones from readily available 
starting materials. Our process has been shown to be tolerant of a wide variety of 
functional groups, which makes further elaboration possible.  
Experimental Section 
General 
   The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 and 100 MHz 
respectively. All melting points are uncorrected. High resolution mass spectra were 
recorded using EI at 70 eV. All reagents were used directly as obtained commercially 
unless otherwise noted. All reactions were carried out in oven-dried glassware and 
monitored by thin layer chromatography (SiO2, hexanes or hexanes/EtOAc). THF was 
distilled over Na. The silylaryl triflate 2a, CsF, TBAF solution (1M in THF) and 
acetonitrile were purchased from Sigma-Aldrich Co. 4,5-Dimethyl-substituted silylaryl 
triflate 2b, 4,5-dimethoxy-substituted silylaryl triflate 2c and 4,5-difluoro-substituted 
silylaryl triflate 2d were prepared according to a previous literature procedure.21  
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Non-commercially available compounds   
    Non-commercially available starting materials were prepared according to literature 
procedures.22  
 
N-Benzyl-2-bromo-5-methylbenzamide (1m): white solid, mp 133-135 °C; 1H NMR 
(300 MHz, CDCl3) δ 7.41-7.21 (m, 7H), 7.04 (dd, J = 9.0, 3.0 Hz, 1H), 6.47 (s, 1H), 4.59 
(d, J = 3.0 Hz, 2H), 2.28 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 167.78, 137.82, 137.74, 
137.38, 133.16, 132.20, 130.33, 128.81, 128.08, 127.69, 115.94, 44.21, 20.89; HRMS 
(EI) calcd for C15H14NOBr: 304.0258, found 304.0255.  
 
N-Benzyl-2-bromo-5-(trifluoromethyl)benzamide (1r): white solid, mp 148-150 °C; 1H 
NMR (300 MHz, d6-DMSO) δ 9.17 (t, J = 6.0 Hz, 1H), 7.93 (d, J = 9.0 Hz, 1H), 7.80 (s, 
1H), 7.74 (dd, J = 9.0, 3.0 Hz, 1H), 7.42-7.25 (m, 5H), 4.50 (d, J = 6.0 Hz, 2H); 13C NMR 
(300 MHz, d6-DMSO) δ 166.04, 139.92, 138.73, 134.05, 128.35, 127.43, 127.39, 126.96, 
125.48, 125.43, 123.87, 121.86, 42.66; HRMS (EI) calcd for C15H11NOBrF3: 357.9966, 
found 357.9967.  
 
N-Benzyl-2-bromo-4-nitrobenzamide (1u): white solid, mp 148-150 °C; 1H NMR (300 
MHz, CDCl3) δ 8.42 (s, 1H), 8.17 (dd, J = 9.0, 3.0 Hz, 1H), 7.65 (d, J = 9.0 Hz, 1H), 
7.37-7.26 (m, 5H), 6.39 (br s, 1H), 4.63 (d, J = 6.0 Hz, 2H); 13C NMR (300 MHz, CDCl3) 
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δ 165.90, 148.73, 143.53, 137.13, 130.33, 129.07, 128.60, 128.21, 128.16, 122.70, 
120.20, 44.55; HRMS (EI) calcd for C14H11N2O3Br: 334.9933, found 334.9951.  
  
 
2-Bromo-N,N’-dibenzyl-1,4-benzenedicarboxamide (1v): white solid, mp 219-221 °C; 
1H NMR (300 MHz, d6-DMSO) δ 9.28 (t, J = 6.0 Hz, 1H), 9.09 (t, J = 6.0 Hz, 1H), 8.18 
(s, 1H), 7.95 (d, J = 9.0 Hz, 1H), 7.55 (d, J = 9.0 Hz, 1H), 7.41-7.25 (m, 10H), 4.49 (d, J 
= 6.0 Hz, 2H;); 13C NMR (300 MHz, d6-DMSO) δ 168.86, 164.23, 141.36, 139.27, 
138.95, 136.31, 131.35, 128.84, 128.36, 128.35, 127.32, 126.91, 126.89, 126.62, 118.99, 
42.83, 42.49; HRMS (EI) calcd for C22H19N2O2Br: 422.0630, found 422.0625.  
General Procedure for the Palladium-Catalyzed Synthesis of Phenanthridinones 
The 2-bromobenzamide (1a) (0.25 mmol), the 2-(trimethylsilyl)aryl triflate (2.0 equiv), 
CsF (5.0 equiv), Na2CO3 (1.0 equiv), Pd(OAc)2 (5 mol %), dppm (10 mol %), 4 ml of 
toluene, and 1 ml of MeCN were placed in a 4 dram vial, and the vial was sealed. The 
reaction mixture was stirred first at room temperature for 1 min and then heated to 110 ºC 
for 16-24 h. The mixture was allowed to cool to room temperature, diluted with ethyl 
acetate, washed with brine, dried over anhydrous MgSO4, and concentrated under reduced 
pressure. The product was isolated by flash chromatography on silica gel using 
hexanes/EtOAc as the eluent. 
N
O
Et
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5-Ethylphenanthridin-6(5H)-one (3a): white solid, mp 98-99 °C; 1H NMR (300 MHz, 
d6-acetone) δ 8.48-8.44 (m, 4H), 7.82 (td,  J = 9.0, 3.0 Hz, 1H), 7.65-7.59 (m, 3H), 7.35-
7.30 (m, 1H), 4.46 (q, J = 6.0 Hz, 2H), 1.35 (t, J = 6.0 Hz, 3H); 13C NMR (300 MHz, d6-
acetone) δ 160.39, 137.27, 133.83, 132.62, 130.00, 128.50, 128.01, 125.88, 123.85, 
122.35, 122.17, 119.30, 115.65, 115.28, 37.29, 12.39; HRMS (EI) calcd for C15H13NO: 
223.0997, found 223.0995.  
 
5-Isopropylphenanthridin-6(5H)-one (3b): white solid, mp 99-101 °C; 1H NMR (300 
MHz, d6-acetone) δ 8.44 (dd, J = 9.0, 3.0 Hz, 3H), 7.84-7.76 (m, 2H), 7.64-7.54 (m, 2H), 
7.32 (t, J = 9.0 Hz, 1H), 5.42 (m, 1H), 1.68 (d, J = 9.0 Hz, 9H); 13C NMR (300 MHz, d6-
acetone) δ 162.49, 135.08, 133.79, 130.79, 129.60, 129.20, 128.03, 125.27, 123.48, 
123.26, 121.11, 117.16, 49.12, 20.54; HRMS (EI) calcd for C16H15NO: 237.1154, found 
237.1152.  
 
5-Cyclohexylphenanthridin-6(5H)-one (3c): white solid, mp 117-120 °C; 1H NMR (300 
MHz, CDCl3) δ 8.50 (d, J = 7.8 Hz, 1H), 8.23 (dd, J = 10.0, 7.5 Hz, 2H), 7.74-7.45 (m, 
5H), 7.26 (t, J = 7.2 Hz, 1H), 2.72 (m, 1H), 2.00-1.76 (m, 6H), 1.56-1.36 (m, 4H); 13C 
NMR (300 MHz, CDCl3) δ 162.23, 138.05, 133.70, 132.34, 129.07, 128.71, 127.97, 
126.79, 123.74, 122.22, 121.53, 120.26, 115.90, 57.88, 29.25, 26.89, 25.73; HRMS (EI) 
calcd for C19H19NO: 277.1467, found 277.1465.  
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5-tert-Butylphenanthridin-6(5H)-one (3d): white solid, mp 128-130 °C; 1H NMR (300 
MHz, d6-acetone) δ 8.30-8.21 (m, 3H), 7.76-7.72 (m, 2H), 7.56 (t, J = 9.0 Hz, 1H), 7.42 
(t, J = 9.0 Hz, 1H), 7.25 (td, J = 9.0, 3.0 Hz, 1H), 1.79 (s, 9H); 13C NMR (300 MHz, 
CDCl3) δ 165.59, 138.09, 133.86, 132.13, 129.63, 127.89, 127.73, 126.76, 123.82, 
122.68, 122.23, 121.53, 120.77, 60.72, 30.66; HRMS (EI) calcd for C17H17NO: 251.1310, 
found 251.1311.  
 
5-(4-Methlylbenzyl)phenanthridin-6(5H)-one (3h): white solid, mp 106-108 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.62 (d, J = 8.1 Hz, 1H), 8.27 (t, J = 6.3 Hz, 1H), 7.77 (t, J = 
7.2 Hz, 1H), 7.60 (t, J = 7.2 Hz, 1H), 7.36-7.07 (m, 8H), 5.61 (s, 2H), 2.28 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 162.06, 137.55, 136.97, 134.00, 133.73, 132.82, 129.71, 
129.64, 129.34, 128.18, 126.70, 125.64, 123.42, 122.69, 121.85, 119.67, 116.22, 46.44, 
21.26; HRMS (EI) calcd for C21H17NO: 299.1310, found 299.1307.  
 
5-(4-Nitrobenzyl)phenanthridin-6(5H)-one (3j): white solid, mp 235-237 °C; 1H NMR 
(300 MHz, CDCl3) δ 8.60 (d, J = 9.0 Hz, 1H), 8.36 (d, J = 9.0 Hz, 2H), 8.25 (dd, J = 6.0, 
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3.0 Hz, 1H), 7.85 (t, J = 9.0 Hz, 1H), 7.65 (t, J = 9.0 Hz, 1H), 7.42-7.27 (m, 4H), 7.09 (d, 
J = 9.0 Hz, 1H), 6.99 (dd, J = 6.0, 3.0 Hz, 1H), 6.05 (s, 2H); 13C NMR (300 MHz, CDCl3) 
δ 166.60, 137.25, 134.40, 133.29, 132.56, 130.10, 129.41, 128.50, 128.36, 127.69, 
125.91, 125.41, 123.82, 123.27, 122.05, 119.86, 115.74, 45.07; HRMS (EI) calcd for 
C20H14N2O3: 330.1004, found 330.1011.  
 
 5-Benzyl-9-methylphenanthridin-6(5H)-one (3l): white solid, mp 173-175 °C; 1H 
NMR (300 MHz, d6-acetone) δ 8.47 (d, J = 6.0 Hz, 1H), 8.42 (d, J = 6.0 Hz, 1H), 8.35 (s, 
1H), 7.51 (d, J = 9.0 Hz, 1H), 7.43 (dd, J = 6.0, 3.0 Hz, 2H), 7.31-7.23 (m, 6H), 5.70 (s, 
2H), 2.59 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 162.10, 143.40, 137.65, 136.88, 133.99, 
129.65, 129.59, 129.36, 128.96, 127.32, 126.69, 123.40, 122.61, 121.92, 119.68, 116.19, 
46.57, 22.42; HRMS (EI) calcd for C21H17NO: 299.1310, found 299.1304. 
 
5-Benzyl-8-methylphenanthridin-6(5H)-one (3m): white solid, mp 173-175 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.43 (s, 1H), 8.25 (d, J = 7.8 Hz, 1H), 8.19 (d, J = 8.4 Hz, 
1H), 7.61 (dd, J = 8.1, 1.8 Hz, 1H), 7.38-7.21 (m, 8H), 5.67 (s, 2H), 2.54 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 162.16, 138.40, 137.15, 136.87, 134.22, 131.56, 129.23, 
129.09, 128.96, 127.33, 126.71, 125.45, 123.21, 122.68, 121.90, 119.84, 116.14, 46.63, 
21.58; HRMS (EI) calcd for C21H17NO: 299.1310, found 299.1306. 
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5-Benzyl-10-methoxyphenanthridin-6(5H)-one (3n): white solid, mp 122-123 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.62 (d, J = 9.0 Hz, 1H), 8.46 (d, J = 6.0 Hz, 1H), 7.65 (d, J = 
9.0 Hz, 1H), 7.52 (t, J = 9.0 Hz, 1H), 7.38-7.23 (m, 8H), 5.67 (s, 2H), 2.97 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 162.39, 137.70, 137.36, 136.78, 134.67, 133.50, 128.98, 
128.82, 128.11, 127.82, 127.48, 127.32, 126.67, 121.87, 121.25, 116.01, 46.98, 26.31; 
HRMS (EI) calcd for C21H17NO: 299.1310, found 299.1303.  
N
O
BnMeO
 
5-Benzyl-8-methoxyphenanthridin-6(5H)-one (3o): white solid, mp 133-135 °C; 1H 
NMR (300 MHz, d6-acetone) δ 8.42 (d, J = 9.0 Hz, 1H), 8.36 (d, J = 6.0 Hz, 1H), 7.96 (d, 
J = 3.0 Hz, 1H), 7.46-7.24 (m, 9H), 5.71 (s, 2H), 3.98 (s, 3H); 13C NMR (300 MHz, d6-
acetone) δ 162.30, 161.17, 138.77, 137.79, 130.05, 129.89, 128.71, 128.40, 128.26, 
128.02, 125.48, 124.34, 123.92, 123.34, 120.78, 117.42, 110.94, 56.52, 47.12; HRMS 
(EI) calcd for C21H17NO2: 315.1259, found 315.1259.  
N
O
BnMeO
MeO
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5-Benzyl-8,9-dimethoxyphenanthridin-6(5H)-one (3p): white solid, mp 210-212 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.13 (d, J = 7.8 Hz, 1H), 7.98 (s, 1H), 7.59 (s, 1H), 7.38-7.21 
(m, 8H), 5.65 (s, 2H), 4.09 (s, 3H), 4.04 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 161.53, 
153.60, 149.99, 137.00, 136.95, 128.93, 128.81, 128.75, 127.29, 126.68, 122.82, 122.49, 
119.54, 119.51, 116.17, 109.41, 102.73, 56.36, 56.30, 46.60; HRMS (EI) calcd for 
C22H19NO3: 345.1365, found 345.1370.  
 
5-Benzyl-8-chlorophenanthridin-6(5H)-one (3q): white solid, mp 155-157 °C; 1H NMR 
(300 MHz, CDCl3) δ 8.59 (d, J = 2.1 Hz, 1H), 8.23 (d, J = 9.0 Hz, 1H), 8.22 (d, J = 8.1 
Hz, 1H), 7.73 (dd, J = 8.1, 2.4 Hz, 1H), 7.41 (m, 1H), 7.32-7.24 (m, 7H), 5.65 (s, 2H); 13C 
NMR (300 MHz, CDCl3) δ 161.05, 137.39, 136.47, 134.47, 133.23, 132.48, 130.10, 
129.06, 128.91, 127.51, 126.85, 126.70, 123.71, 123.49, 123.04, 119.00, 116.36, 46.83; 
HRMS (EI) calcd for C20H14NOCl: 319.0764, found 319.0756.  
 
5-Benzyl-8-(trifluoromethyl)phenanthridin-6(5H)-one (3r): white solid, mp 186-188 
°C; 1H NMR (300 MHz, CDCl3) δ 8.92 (s, 1H), 8.41 (d, J = 8.4 Hz, 1H), 8.30 (dd, J = 8.1, 
1.5 Hz, 1H), 7.99 (dd, J = 8.7, 1.8 Hz, 1H), 7.47 (m, 1H), 7.36-7.24 (m, 7H), 5.67 (m, 
2H); 13C NMR (300 MHz, CDCl3) δ 161.28, 138.14, 136.33, 131.05, 129.10, 129.04, 
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128.99, 127.60, 127.09, 126.98, 126.73, 125.68, 124.08, 123.19, 122.89, 118.61, 116.49, 
46.86; HRMS (EI) calcd for C21H14NOF3: 353.1027, found 353.1035.  
 
5-Benzyl-9-nitrophenanthridin-6(5H)-one (3u): yellow solid, decomposes above 300 
°C; 1H NMR (300 MHz, CDCl3) δ 9.18 (d, J = 2.1 Hz, 1H), 8.80 (d, J = 8.7 Hz, 1H), 8.41-
8.36 (m, 2H), 7.56-7.50 (m, 2H), 7.40-7.27 (m, 6H), 5.69 (s, 2H); 13C NMR (300 MHz, 
CDCl3) δ 167.98, 160.74, 138.07, 136.03, 135.22, 131.54, 131.35, 131.10, 129.17, 
129.01, 127.72, 126.69, 124.03, 123.55, 121.93, 118.50, 117.86, 116.61, 47.08; HRMS 
(EI) calcd for C20H14N2O3: 330.1004, found 330.1001.  
 
5-Benzyl-9-[(benzylamino)carbonyl]phenanthridin-6(5H)-one (3v): white solid, mp 
197-200 °C; 1H NMR (300 MHz, CDCl3) δ 8.80 (s, 1H), 8.58 (d, J = 8.1 Hz, 1H), 8.30 (d, 
J = 7.8 Hz, 1H), 7.85 (dd, J = 8.4, 1.5 Hz,  1H), 7.33-7.22 (m, 3H), 6.88 (s, 1H), 5.61 (s, 
2H), 4.72 (d, J = 5.7 Hz, 2H); 13C NMR (300 MHz, CDCl3) δ 166.84, 161.41, 138.14, 
137.97, 136.35, 134.28, 130.27, 129.79, 129.01, 128.99, 128.19, 127.93, 127.44, 126.60, 
125.33, 123.79, 123.01, 121.88, 119.16, 116.22, 46.74, 44.58; HRMS (EI) calcd for 
C28H22N2O2: 418.1681, found 418.1689. 
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6-Benzylbenzo-1,6-naphthyridin-5-one (3w): white solid, mp 129-131 °C; 1H NMR 
(300 MHz, CDCl3) δ 9.04 (dd, J = 6.0, 3.0 Hz, 1H), 8.90 (d, J = 9.0 Hz, 1H), 8.83 (dd, J = 
9.0, 3.0 Hz, 1H), 7.57-7.47 (m, 2H), 7.37-7.24 (m, 7H), 5.66 (s, 2H); 13C NMR (300 
MHz, CDCl3) δ 162.12, 154.20, 138.77, 137.24, 136.43, 131.53, 129.07, 127.56, 126.72, 
125.53, 123.30, 123.21, 121.07, 115.71, 46.65; HRMS (EI) calcd for C19H14N2O: 
286.1106, found 286.1098.  
 
5-Benzyl-2,3-dimethylphenanthridin-6(5H)-one (3gb): white solid, mp 155-157 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.64-8.58 (m, 1H), 8.32-8.25 (m, 1H), 8.01 (s, 1H), 7.78-7.73 
(m, 1H), 7.65-7.54 (m, 1H), 7.32-7.25 (m, 3H), 7.09 (s, 1H), 6.87 (d, J = 12.0 Hz, 2H), 
5.64 (s, 2H), 3.90 (s, 3H), 3.88 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 162.07, 138.94, 
137.07, 132.89, 132.70, 129.75, 129.38, 129.00, 128.96, 128.24, 127.27, 126.71, 123.48, 
121.89, 116.23, 46.56, 20.68, 19.62; HRMS (EI) calcd for C22H19NO: 313.1467, found 
313.1470.  
 
5-Benzyl-2,3-dimethoxyphenanthridin-6(5H)-one (3gc): white solid, mp 153-155 °C; 
1H NMR (300 MHz, CDCl3) δ 8.61 (dd, J = 8.1, 1.5 Hz, 1H), 8.14 (d, J = 8.1, 1H), 7.76 
(td, J = 8.1, 1.5 Hz, 1H), 7.64 (s, 1H), 7.56 (t, J = 8.1 Hz, 1H), 7.30-7.23 (m, 5H), 6.79 (s, 
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1H), 5.66 (s, 2H), 3.99 (s, 3H), 3.75 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 162.16, 
150.77, 145.32, 137.08, 134.01, 132.75, 132.42, 129.53, 129.09, 127.53, 127.16, 126.81, 
124.72, 121.32, 112.37, 105.37, 100.07, 56.50, 56.06, 47.07; HRMS (EI) calcd for 
C22H19NO3: 345.1365, found 345.1370.  
 
5-Benzyl-2,3-difluorophenanthridin-6(5H)-one (3gd): white solid, mp 187-189 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.61 (d, J = 9.0 Hz, 1H), 8.05 (m, 1H), 7.82 (t, J = 9.0 Hz, 
1H), 7.65 (d, J = 9.0 Hz, 1H), 7.35-7.08 (m, 7H), 5.60 (s, 2H); 13C NMR (300 MHz, 
CDCl3) δ 161.90, 152.65, 148.07, 136.75, 135.88, 133.28, 129.63, 129.24, 129.01, 
128.74, 128.27, 127.78, 127.39, 126.65, 116.26, 111.83, 105.60, 47.17;  HRMS (EI) calcd 
for C20H13NOF2: 321.0965, found 321.0973.  
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Abstract 
N-Acylcarbazoles have been synthesized in good yields by the annulation of in situ 
generated arynes with 2-haloacetanilides in the presence of a palladium catalyst and CsF. 
Both C-C and C-N bond can be formed simultaneously and a variety of  functional groups 
are tolerated in this reaction. 
Introduction 
Carbazole alkaloids have been found to possess a variety of biological activities, 
including anti-bacterial, anti-fungal, anti-viral, anti-flammatory, and anti-tumor 
properties.1 In addition to their use in the pharmaceutical field, some carbazole 
derivatives also find applications in material science, for example as photorefractive 
materials.2 
    Synthetic applications of aryne chemistry have attracted considerable attention3 since a 
convenient approach to aryne generation by the fluoride induced 1,2-elimination of o-
(trimethylsilyl)aryl triflates was first reported in 1983.4 The high electrophilicity of arynes 
has been used extensively in our group in the construction of heteroaromatic structures 
via either simple nucleophilic reactions5 or annulation reactions.6 Palladium-mediated 
reactions are by far the most powerful metal-catalyzed processes for constructing 
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carbocycles and heterocycles,7 due to the high efficiency with which they construct C-C 
and C-X (X = O, N) bonds7 and their high compatibility with functional groups. To take 
advantage of the high reactivity and tremendous synthetic utility of arynes and the 
tremendous versatility of organopalladium chemistry, we8 and several other groups9 have 
been exploring the palladium-catalyzed annulation reactions of arynes. 
    Herein, we wish to report the palladium-catalyzed annulation of arynes by substituted 
2-haloacetanilides to produce N-acylcarbazoles in decent yields. In this reaction, C-C and 
C-N bonds are formed simultaneously to generate this important heterocyclic ring system.   
Results and discussion 
Optimization studies  
We attempted to optimize the reaction of 2-iodoacetanilide (1a) and the benzyne 
precursor o-(trimethylsilyl)phenyl trifluoromethanesulfonate (2a) in 4:1 
toluene/acetonitrile with CsF as the fluoride source (Table 1). In all cases, there was 
always side product 4a generated by the cyclotrimerization of benzyne,10 plus the desired 
benzyne annulation product 3a (eq 1). Optimization work was conducted with respect to 
different palladium catalysts, ligands, and solvents and the results are shown in Table 1.   
Utilizing Pd(dba)2 as the catalyst, several ligands were examined (entries 1-9) in a 4:1 
toluene/acetonitrile mixed solvent. A low yield (23%) of the desired product was 
produced with the aryl halide 1a left in large amounts, when employing tri(o-
tolyl)phosphine as the ligand (entry 1). Bidentate ligands were also tested. Both dppm and 
dppb give low yields: 42% (entry 2) and 27% (entry 3) respectively. However, dppf 
improves the yield of the desired product dramatically to 69% (entry 4). Several different 
biarylphosphine ligands  (L1-L5, Scheme 1) have also been examined in this process 
(entries 5-9), but the yield was only increased to around 50%.  
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Table 1. Optimization of the Pd-Catalyzed Annulation of Benzyne (eq 1)a 
 
 entry             cat.                            ligand                            solvent                   % yield b 
                  (5 mol %)                     (mol %)                    (toluene/MeCN)            of 3a  
1 Pd(dba)2 P(o-tolyl)3 (10) 4:1 23 
2 Pd(dba)2 dppm  (10) 4:1 42 
3 Pd(dba)2 dppb  (10) 4:1 27 
4 Pd(dba)2 dppf (10) 4:1 69 
5 Pd(dba)2 L1  (10)c 4:1 45 
6 Pd(dba)2 L2  (10)c 4:1 54 
7 Pd(dba)2 L3 (10)c 4:1 56 
8 Pd(dba)2 L4  (10)c 4:1 51 
9 Pd(dba)2 L5  (10)c 4:1 17 
   10 Pd(OAc)2 dppf  (10) 4:1 54 
   11 Pd(PPh3)4 dppf  (10) 4:1 60 
   12 Pd(dba)2 dppf  (5) 4:1 60 
   13 Pd(dba)2 dppf  (10) 3:1 54 
   14 Pd(dba)2 dppf  (10) 5:1 35 
   15 Pd(dba)2 dppf  (10) C3H7CN 61 
   16 Pd(dba)2 dppf  (10) DMEd 45 
aAll reactions were run using substrate 1a (0.25 mmol), 2.0 equiv of  2a, 5.0 equiv of  
CsF, 10 ml of  solvent at 110 °C for 24 h unless otherwise specified. bIsolated  yield.  
cSee L in Scheme 1. d The reaction was conducted at 90 °C for 36 h.  
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Scheme 1. Phosphine ligands examined 
 
 
 
Besides examining the ligand, several commonly used Pd catalysts, including 
Pd(OAc)2 and Pd(PPh3)4, were also tested in this reaction (entries 10 and 11). Pd(dba)2 
proved to be the most efficient. An effort to lower the ligand loading (entry 12) was 
made, but 10% dppf seemed necessary to maintain a decent yield. Based on our previous 
experience, the solvent can often prove critical for palladium-catalyzed benzyne 
reactions, mostly because the benzyne is generated at vastly different rates in different 
solvents.8  With a toluene/acetonitrile mixed solvent and CsF as the fluoride source, 
benzyne is generated more slowly in mixtures  with less acetonitrile, because CsF has a 
lower solubility in toluene. So the solvent ratio was tested and 4:1 toluene/acetonitrile 
afforded the best result (entries 13 and 14). With a 3:1 ratio, more side product, trimer 4a, 
was formed. With a 5:1 ratio, the benzyne was generated too slowly, leading to a lower 
yield. Other solvents, including butyronitrile11 (entry 15) and DME (entry 16), afforded 
only moderate yields. In the end, we have chosen the reaction conditions reported  in 
entry 4 of Table 1 as our optimal conditions.        
Synthesis of  N-acylcarbazoles  
    In order to explore the scope and limitations of this chemistry, a number of o-
haloacetanilide related amides were synthesized and were allowed to react with 2-
76 
 
(trimethylsilyl)phenyl trifluoromethanesulfonate (2a) under our optimized conditions. 
The results are summarized in Table 2. 
Different substituents in the acyl groups of the starting amides, including alkyl (entries 
1-4), benzyl (entry 5), and phenyl (entries 6-8) groups, have been examined and decent 
yields have been produced, except for the reaction of amide 6, which generated only trace 
amounts of the desired product along with a large amount of dehalogenated product and 
unidentified polymeric material. It is worth noting that the electronic nature of the phenyl 
group in the acyl substituent has a significant impact on the reaction yield (compare 
entries 6, 7, and 8). Thus, a substrate with a more electron-rich phenyl group (9) (entry 7) 
afforded a much higher yield than a similar substrate with a more electron-deficient 
phenyl group (10) (entry 8). This phenomena can be explained as follows. An electron-
donating OMe group can increase the nucleophilicity of the nitrogen, which promotes 
nucleophilic attack of the nitrogen on Pd(II) in the cyclization step in going from complex 
III to complex V (see Scheme 2). On the other hand, an electron-withdrawing CF3 group 
decreases the nucleophilicity, inhibiting the cyclization step. These experimental results 
suggest that the nucleophilicity of nitrogen, which is involved in the cyclization step from 
complex III to complex V (see Scheme 2), is critical for this reaction. An acetanilide with 
a thiophenyl substituent (11, entry 9) has also been tested and the reaction was observed 
to be messier than an analogous reaction of an alkyl-substituted substrate, producing a 
lower yield of 50%. A lower yield from bromo-aryl 12 (entry 10) was produced than 
when using the corresponding iodoacetanilide 9. This is not suprising, since for most 
palladium-catalyzed reactions of aryl halides, iodine-containing substrates provide better 
results than bromine-containing substrates, because their oxidative addition to Pd(0) is 
easier and faster.  
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Table 2. Pd-Catalyzed Annulation of Benzyne 2aa   
 
entry substrate (product) 
% yieldb 
entry substrate (product) 
% yieldb 
 
 
1 
 
 
 
(1) 
 
 
(3) 69 
 
 
10 
 
 
 
(12) 
 
 
(35) 60 
 
 
2 
 
 
(4) 
 
 
(30) 70 
 
 
11 
 
 
(13) 
 
 
(38)65 
 
 
3 
 
 
(5) 
 
 
(31) 73 
 
 
12 
 
 
(14) 
 
 
(39)74 
 
 
4 
 
 
(6) 
 
 
(32) trace 
 
 
 
13 
 
 
(15) 
 
 
(40) 44 
 
 
5 
 
 
 
(7) 
 
 
(33) 61 
 
 
14 
 
 
 
 
(16) 
 
 
(41) 77 
 
 
6 
 
 
 
(8) 
 
 
(34) 60 
 
 
15 
 
 
(17) 
 
 
(42) 55 
 
 
 
7 
 
 
 
 
(9) 
 
 
 
(35) 76 
 
 
 
16 
 
 
(18) 
 
 
 
(43) 34 
 
 
8 
 
 
(10) 
 
 
(36) 33 
 
 
17 
 
 
 
(19) 
 
 
 
(44) 40 
 
 
9 
 
 
 
(11) 
 
 
(37) 50 
 
 
18 
 
 
 
                     (20) 
 
 
 
(45) 60 
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entry substrate (product) 
% yieldb 
entry substrate (product) 
% yieldb 
 
 
19 
 
 
 
(21) 
 
 
(46) 55 
 
 
24 
 
 
(26) 
 
 
(51) 54 
 
 
20 
 
 
 
(22) 
 
 
(47) 63 
 
 
25 
 
 
 
(27) 
 
 
(52) 43 
 
 
21 
 
 
 
 
(23) 
 
 
(48) 65  
 
 
26 
 
 
(28) 
 
 
(53) 30 
 
 
22 
 
 
(24) 
 
 
(49) 53 
 
 
27 
 
 
(29) 
 
 
 
   (54) 
27 (50c) 
 
 
 
23 
 
 
 
 
(25) 
 
 
(50) 40  
  
 
aRepresentative procedure: 1 (0.25 mmol), 2.0 equiv of 2, 5.0 equiv of CsF, 5 mol % Pd(dba)2, 10 mol 
% dppf in 10 ml of 4:1 toluene/MeCN at 110 oC for 24 h unless otherwise specified. bIsolated yield. 
cThe reaction was conducted in 10 ml of  1:1 toluene/MeCN.  
 
 
To further test the scope and the limitations of the reaction, we examined a variety of 
N-(2-iodophenyl)benzamides with various functional groups, including halogens (entries 
18-22), electron-donating groups (entries 11-17), and electron-withdrawing groups 
(entries 23-27). Halogen atoms, including Br (entry 18), Cl (entries 19 and 20) and F 
(entries 21 and 22), are tolerated in this chemistry and decent yields are obtained for the 
corresponding amides, allowing further elaboration of these products via versatile metal-
catalyzed reactions. Amides with a slightly electron-donating methyl group in the 4 (entry 
12), and 5 (entry 11) positions and amides substituted with two methyl groups (entry 14) 
afford high yields of 74%, 65% and 77% respectively. An amide with a methyl group 
ortho to the iodine generates a much lower yield (44%) (entry 13), presumably because 
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the steric hindrance caused by the methyl group disfavors the oxidative addition step (see 
the later mechanistic discussion). Amides with strong electron-donating methoxy groups 
(entries 15-17) provide low yields of around 40%. Again this is presumably because 
electron-rich aryl halides undergo more sluggish oxidative addition in Pd chemistry. 
Strong electron-withdrawing CF3, CN, ester, and NO2 groups (1l, entry 12) lower the 
yield under our “optimal” conditions. We think the reason is that although these electron-
withdrawing groups electronically benefit oxidative addition of the aryl halide to Pd(0), 
they strongly disfavor nucleophilic attack of the nitrogen on Pd(II) in complex III in the  
cyclization step to form complex V (see Scheme 2).  
Table 3.  Investigation of Different Arynes in the Pd-Catalyzed Annulation of  
 o-Haloacetanilide 9 a  
 
 
entry aryne precursor (product) % yieldb 
 
 
1 
 
 
 
 
2b 
 
 
  (16) 62 
 
 
 
2 
 
 
 
 
 
 
 
 
2c 
 
 
 
(44) 40c 
 
 
 
3 
 
 
 
 
 
 
2d 
 
 
(55) 0 
 
a
 Representative procedure: 9 (0.25 mmol), 2.0 equiv of the aryne precursor, 5.0 equiv of 
CsF, 5 mol % Pd(dba)2, 10 mol % dppf  in 10 ml of 4:1 toluene/MeCN at 110 oC for 24 h. 
b
 Isolated yield. c  Reaction was conducted for 48 h. 
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   In addition to the above reactions, which examined only the use of the benzyne 
precursor triflate 2a as an annulation partner, other aryne precursors have been examined 
in our methodology (Table 3). When 4,5-dimethylbenzyne precursor 2b was allowed to 
react with amide 9 under our optimized conditions, it provided the corresponding 
annulation product 16 in a decent yield. Dimethoxybenzyne precursor 2c was also 
examined and a longer reaction time was necessary to get a 40% yield of the annulation 
product 44 (Table 3, entry 2). The low yield for 2c may be attributed to the slower rate of 
generation of 4,5-dimethoxybenzyne compared with the generation of benzyne from 2a, 
as has been suggested by earlier work in our group.12  Difluorobenzyne precursor 2d was 
also allowed to react with 1g under the optimal conditions (Table 3, entry 3), but none of 
the desired product was observed and a large amount of 1g was left, presumably due to 
the lack of stability of difluorobenzyne in the reaction system. 
    Based on our experimental results and previous experience with related processes,13 we 
propose that this N-acylcarbazole synthesis proceeds through one of two possible 
pathways shown in Scheme 2. One possible pathway proceeds by the oxidative 
cyclization of Pd(0) with aryne generated from the silyl triflate to form palladacycle I 
(path a).14 Oxidative addition of 1a to this palladacycle forms Pd(IV) intermediate II. 
However, we cannot rule out the possibility that Pd(0) inserts directly into the C-I bond of 
1a to form intermediate IV, which then undergoes carbopalladation of the aryne to give 
rise to intermediate III15 (path b). Then, under the basic conditions, intermediate V may 
be formed. Finally, through reductive elimination the desired product can be generated 
alongside Pd(0), which can reenter the catalytic cycle. However, there does not appear to 
does not appear to be any particular evidence favoring either of these pathways. 
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Scheme 2. Tentative Mechanisms 
 
Conclusions 
   In summary, we have developed a novel method for the synthesis of N-acylcarbazoles, 
which involves the palladium-catalyzed annulation of arynes by 2-haloacetanilides. This 
method provides an efficient synthesis of carbazole derivatives from readily available 
starting materials. Our process has been shown to be tolerant of various functional groups, 
which makes further elaboration of these substrates possible.  
Experimental Section 
General 
    The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 and 100 MHz 
respectively. All melting points are uncorrected. High resolution mass spectra were 
recorded using EI at 70 eV. All reagents were used directly as obtained commercially 
unless otherwise noted. CsF, acetonitrile and silyaryl triflate 2a were purchased from 
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Sigma-Aldrich Co. 4,5-Dimethyl-substituted silylaryl triflate 2b, 4,5-dimethoxy-
substituted silylaryl triflate 2c and 4,5-difluoro-substituted silylaryl triflate 2d were 
prepared according to a previous literature procedure.16 
Non-commercial compounds 
 
    Non-commercially available starting materials were prepared according to literature 
procedures.17  
 
N-(2-Iodophenyl)-4-(trifluoromethyl)benzamide (10): white solid, mp 173-175 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.33 (d, J = 9.0 Hz, 1H), δ 7.82 (d, J = 9.0 Hz, 1H), 7.71-7.63 
(m, 5H), 7.42 (t, J = 6.0 Hz, 1H), 6.92 (t, J = 9.0 Hz, 1H); 13C NMR (300 MHz, d6-
DMSO) δ 165.80, 139.03, 135.83, 132.48, 130.20, 128.88, 128.50, 128.42, 128.14, 
126.49, 126.43; HRMS (EI) calcd for C14H9NOF3Br: 390.9681, found 390.9689.  
 
N-(2-Iodo-5-methylphenyl)-4-methoxybenzamide (13): white solid, mp 95-98 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.31 (d, J = 1.8 Hz, 1H), 8.18 (s, 1H), 7.94 (d, J = 9.0 Hz, 
2H), 7.66 (d, J = 8.1 Hz, 1H), 7.02 (d, J = 9.0 Hz, 2H), 6.71 (dd, J = 8.1, 2.1 Hz, 1H), 
3.89 (s, 3H), 2.37 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 164.96, 162.92, 139.93, 138.47, 
138.33, 129.25, 127.06, 126.99, 122.56, 114.33, 86.34, 55.69, 21.54; HRMS (EI) calcd 
for C15H14NO2I: 367.0069, found 367.0077.  
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N-(2-Iodo-3-methylphenyl)-4-methoxybenzamide (15): white solid, mp 148-150 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.41 (s, 1H), 8.24 (d, J = 6.0 Hz, 1H), 7.96 (d, J = 6.0 Hz, 
2H), 7.27 (t, J = 9.0 Hz, 1H), 7.05-6.99 (d, J = 6.0 Hz, 3H), 3.88 (s, 3H), 2.50 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 165.01, 162.87, 142.43, 138.75, 129.29, 128.85, 127.14, 
125.76, 119.16, 114.30, 98.02, 55.68, 29.88; HRMS (EI) calcd for C15H14NO2I: 
367.0069, found 367.0069.  
 
N-(4,5-Dimethyl-2-iodophenyl)-4-methoxybenzamide (16): white solid, mp 125-127 
°C; 1H NMR (300 MHz, CDCl3) δ 8.19 (s, 1H), 8.08 (s, 1H), 7.93 (d, J = 9.0 Hz, 2H), 
7.55 (s, 1H), 7.00 (d, J = 6.0 Hz, 2H), 3.88 (s, 3H), 2.26 (s, 3H), 2.20 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 164.90, 162.82, 139.11, 138.33, 136.29, 135.01, 133.01, 129.21, 
127.06, 123.10, 114.28, 86.76, 55.67, 20.03, 19.10; HRMS (EI) calcd for C16H16NO2I: 
381.0226, found 381.0227.  
 
N-(2-Iodo-5-methoxyphenyl)-4-methoxybenzamide (17): white solid, mp 107-110 °C; 
1H NMR (300 MHz, CDCl3) δ 8.23-8.22 (m, 2H), 7.93 (d, J = 8.7 Hz, 2H), 7.62 (d, J = 
8.7 Hz, 1H), 7.00 (d, J = 8.7 Hz, 2H), 6.49 (dd, J = 8.7, 3.0 Hz, 1H), 3.87 (s, 3H), 3.84 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 165.04, 162.97, 160.89, 139.42, 138.71, 132.99, 
129.22, 126.87, 114.35, 113.12, 106.75, 78.26, 55.69, 55.67; HRMS (EI) calcd for 
C15H14NO3I: 383.0015, found 383.0023.  
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N-(2-Iodo-4-methoxyphenyl)-4-methoxybenzamide (18): white solid, mp 134-135 °C; 
1H NMR (300 MHz, CDCl3) δ 8.37 (d, J = 9.3 Hz, 1H), 8.16 (s, 1H), 7.88 (d, J = 6.9 Hz, 
1H), 7.02-6.97 (m, 3H), 6.88 (dd, J = 9.0, 3.0 Hz, 1H), 3.88 (s, 3H), 3.81 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 164.89, 162.81, 156.37, 129.12, 128.44, 127.10, 124.38, 
123.12, 114.74, 114.27, 113.48, 55.91, 55.68; HRMS (EI) calcd for C15H14NO3I: 
383.0018, found 383.0028.  
 
N-(4,5-Dimethoxy-2-iodophenyl)-4-methoxybenzamide (19): white solid, mp 168-170 
°C; 1H NMR (400 MHz, CDCl3) δ 8.16 (s, 1H), 8.06 (s, 1H), 7.93 (d, J = 8.0 Hz, 2H), 
7.20 (s, 1H), 7.01 (d, J = 12.0 Hz, 2H), 3.94 (s, 3H), 3.89 (s, 3H), 3.87 (s, 3H); 13C NMR 
(400 MHz, CDCl3) δ 164.94, 162.83, 149.74, 146.40, 132.71, 129.10, 126.82, 120.40, 
114.27, 105.85, 56.46, 56.16, 55.63; HRMS (EI) calcd for C16H16NO4I: 413.0124, found 
413.0121.  
 
N-(4-Bromo-2-iodophenyl)-4-methoxybenzamide (20): white solid, mp 151-152 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.36 (d, J = 8.7 Hz, 1H), 8.19 (s, 1H), 7.93-7.90 (m, 3H), 7.50 
(dd, J = 9.0, 2.1 Hz, 1H), 7.01 (d, J = 8.7 Hz, 2H), 3.88 (s, 3H) ; 13C NMR (300 MHz, 
CDCl3) δ 166.58, 163.12, 140.62, 137.94, 132.53, 129.68, 126.59, 122.54, 117.25, 
114.42, 90.41, 55.73; HRMS (EI) calcd for C14H11NO2IBr: 430.9018, found 430.9029.  
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N-(4-Chloro-2-iodophenyl)-4-methoxybenzamide (21): white solid, mp 148-150 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.41 (d, J = 9.0 Hz, 1H), 8.19 (s, 1H), 7.93 (d, J = 9.0 Hz, 
2H), 7.79 (d, J = 2.4 Hz, 1H), 7.37 (dd, J = 9.0, 2.4 Hz, 1H), 7.01 (d, J = 9.0 Hz, 2H), 
3.89 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 164.96, 163.11, 137.99, 137.51, 129.84, 
129.60, 129.30, 126.60, 122.16, 114.42, 90.01, 55.73; HRMS (EI) calcd for 
C14H11NO2ClI: 386.9523, found 486.9524.  
 
N-(5-Chloro-2-iodophenyl)-4-methoxybenzamide (22): white solid, mp 123-125 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.58 (s, 1H), 8.22 (s, 1H), 7.93 (d, J = 8.0 Hz, 2H), 7.71 (d, J 
= 12.0 Hz, 1H), 7.02 (d, J = 8.0 Hz, 2H), 6.88 (d, J = 8.0 Hz, 1H), 3.89 (s, 3H); 13C NMR 
(400 MHz, CDCl3) δ 164.94, 163.18, 139.59, 139.33, 135.80, 129.33, 126.50, 125.92, 
121.53, 114.45, 86.86, 55.75; HRMS (EI) calcd for C14H11NO2ICl: 386.9523, found 
386.9524.  
 
N-(4-Fluoro-2-iodophenyl)-4-methoxybenzamide (23): white solid, mp 158-160 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.36 (dd, J = 12.0, 8.0 Hz, 1H), 8.09 (s, 1H), 7.92 (d, J = 8.0 
Hz, 2H), 7.54 (dd, J = 8.0, 4.0 Hz, 1H), 7.26 (s, 1H), 7.14 (td, J = 12.0, 4.0 Hz, 1H), 7.01 
(d, J = 8.0 Hz, 2H), 3.89 (s, 3H); 13C NMR (400 MHz, CDCl3) δ 165.01, 163.00, 157.06, 
135.17, 129.25, 125.69, 125.36, 122.84, 116.19, 114.37, 89.89, 55.72; HRMS (EI) calcd 
for C14H11NO2FI: 370.9818, found 370.9823.  
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N-(5-Fluoro-2-iodophenyl)-4-methoxybenzamide (24): white solid, mp 133-135 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.39 (dd, J = 11.0, 2.7 Hz, 1H), 8.29 (s, 1H), 7.94 (d, J = 8.7 
Hz, 2H), 7.74 (dd, J = 8.7, 6.0 Hz, 1H), 7.03 (d, J = 8.7 Hz, 2H), 6.70-6.63 (m, 1H), 3.90 
(s, 3H); 13C NMR (300 MHz, CDCl3) δ 164.91, 163.12, 161.85, 139.27, 139.15, 129.26, 
126.44, 114.39, 113.09, 108.89, 82.50, 55.68; HRMS (EI) calcd for C14H11NO2FI: 
370.9818, found 370.9824.  
 
N-[2-Iodo-4-(trifluoromethyl)phenyl]-4-methoxybenzamide (25): white solid, mp 148-
150 °C; 1H NMR (300 MHz, CDCl3) δ 8.63 (d, J = 9.0 Hz, 1H), 8.38 (s, 1H), 8.04 (s, 1H), 
7.94 (d, J = 9.0 Hz, 2H), 7.64 (d, J = 6.0 Hz, 1H), 7.02 (d, J = 9.0 Hz, 1H), 3.89 (s, 3H); 
13C NMR (300 MHz, CDCl3) δ 165.06, 163.29, 141.73, 135.89, 135.84, 129.39, 126.78, 
126.29, 120.75, 114.38, 88.89, 82.25, 55.73; HRMS (EI) calcd for C15H11NO2F3I: 
420.9782, found 420.9782.  
 
N-[2-Iodo-5-(trifluoromethyl)phenyl]-4-methoxybenzamide (26): white solid, mp 146-
148 °C; 1H NMR (300 MHz, CDCl3) δ 8.83 (d, J = 2.1 Hz, 1H), 8.34 (s, 1H), 7.97-7.92 
(m, 3H), 7.11 (dd, J = 8.1, 2.1 Hz, 1H), 7.03 (d, J = 8.7 Hz, 2H), 3.90 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 165.07, 163.29, 139.43, 139.39, 129.35, 126.34, 122.03, 118.09, 
114.52, 93.74, 55.76; HRMS (EI) calcd for C15H11NO2F3I: 420.9787, found 420.9784.   
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N-(4-Cyano-2-iodophenyl)-4-methoxybenzamide (27): white solid, mp 83-85 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.77 (d, J = 6.0 Hz, 1H), 8.60 (s, 1H), 7.92-7.87 (d, J = 6.0 
Hz, 2H; s, 1H), 7.66 (d, J = 9.0 Hz, 1H), 7.03 (d, J = 9.0 Hz, 2H), 3.90 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 166.58, 163.50, 140.41, 132.87, 129.41, 126.02, 121.04, 117.66, 
113.06, 108.02, 55.79; HRMS (EI) calcd for C15H11N2O2I: 377.9865, found 377.9860.  
 
N-(4-Carbomethoxy-2-iodophenyl)-4-methoxybenzamide (28): white solid, mp 165-
167 °C; 1H NMR (300 MHz, CDCl3) δ 8.60 (d, J = 8.7 Hz, 1H), 8.47 (d, J = 2.1 Hz, 1H), 
8.43 (s, 1H), 8.04 (dd, J = 8.7, 2.1 Hz, 1H), 7.93 (d, J = 9.0 Hz, 2H), 7.01 (d, J = 9.0 Hz, 
2H), 3.91 (s, 3H), 3.88 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.39, 164.96, 163.23, 
142.49, 140.34, 131.12, 129.37, 126.94, 126.40, 120.04, 114.45, 88.88, 55.71, 52.45; 
HRMS (EI) calcd for C16H14NO4I: 410.9968, found 410.9974.  
 
N-(2-Iodo-4-nitrophenyl)-4-methoxybenzamide (29): white solid, mp 158-160 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.76 (d, J = 9.0 Hz, 1H), 8.69 (d, J = 3.0 Hz, 1H), 8.55 (s, 
1H), 8.28 (dd, J = 9.0, 3.0 Hz, 1H), 7.95 (d, J = 9.0 Hz, 2H), 7.04 (d, J = 9.0 Hz, 2H), 
3.90 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.04, 163.60, 144.32, 134.42, 129.53, 
126.15, 125.33, 119.66, 114.64, 87.90, 55.81; HRMS (EI) calcd for C14H11N2O4I: 
397.9763, found 397.9833. 
General Procedure for the Palladium-Catalyzed Synthesis of N-Acylcarbazoles  
The 2-iodoacetanilide (1) (0.25 mmol), the 2-(trimethylsilyl)aryl triflate (2.0 equiv), CsF 
(5.0 equiv), Pd(dba)2 (5 mol %), dppf (10 mol %), 8 ml of toluene, and 2 ml of MeCN 
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were placed in a 4 dram vial, and the vial was sealed. The reaction mixture was stirred 
first at room temperature for 1 min and then heated to 110 °C for 24 h. The mixture was 
allowed to cool to room temperature, diluted with ethyl acetate, washed with brine, dried 
over anhydrous MgSO4, and concentrated under reduced pressure. The product was 
isolated by flash chromatography on silica gel using hexanes/EtOAc as the eluent.  
 
 
 
9-(Cyclohexylcarbonyl)carbazole (31): light brown oil; 1H NMR (300 MHz, CDCl3) δ 
8.17 (d, J = 9.0 Hz, 2H), 8.02 (d, J = 9.0 Hz, 2H), 7.51 (dd, J = 9.0, 6.0 Hz, 2H), 7.40 (dd, 
J = 9.0, 6.0 Hz, 2H), 3.38 (tt, J = 12.0, 3.0 Hz, 1H), 2.14 (d, J = 12.0 Hz, 2H), 1.96 (d, J = 
12.0 Hz, 2H), 1.86-1.74 (m, 3H), 1.60-1.44 (m, 3H); 13C NMR (300 MHz, CDCl3) δ 
177.12, 138.80, 127.52, 126.58, 123.62, 123.62, 119.97, 116.39, 45.46, 29.68, 25.99, 
25.85; HRMS (EI) calcd for C19H19NO: 277.1467, found 277.1466.  
 
 
9-(Phenylacetyl)carbazole (33):  white solid, mp 123-124 °C; 1H NMR (400 MHz, 
CDCl3) δ 8.28 (d, J = 8.0 Hz, 2H), 8.04 (d, J = 8.0 Hz, 2H), 7.51-7.47 (t, J = 8.0 Hz, 2H), 
7.43-7.40 (m, 4H), 7.38-7.34 (m, 3H), 4.53 (s, 2H); 13C NMR (300 MHz, CDCl3) δ 
166.55, 138.74, 133.71, 129.73, 129.02, 127.65, 126.75, 126.14, 124.04, 120.09, 116.71, 
45.61; HRMS (EI) calcd for C20H15NO: 285.1154, found 285.1153.  
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9-(4-Methoxybenzoyl)carbazole (35): white solid, mp 162-164 °C; 1H NMR (300 MHz, 
CDCl3) δ 8.02-7.99 (m, 2H), 7.72 (d, J = 8.7 Hz, 2H), 7.57-7.52 (m, 2H), 7.36-7.30 (m, 
4H), 6.99 (d, J = 9.0 Hz, 2H), 3.90 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 169.30, 
163.40, 139.54, 131.99, 127.74, 126.79, 125.97, 123.23, 120.03, 115.73, 114.29, 55.73; 
HRMS (EI) calcd for C20H15NO2: 301.1103, found 301.1104.  
 
9-[4-(Trifluoromethyl)benzoyl]carbazole (36): white solid, mp 101-103 °C; 1H NMR 
(300 MHz, CDCl3) δ 8.00 (d, J = 9.0 Hz, 2H), 7.93 (d, J = 9.0 Hz, 1H), 7.79-7.70 (m, 
2H), 7.53 (d, J = 6.0 Hz, 1H), 7.44-7.27 (m, 6H); 13C NMR (300 MHz, CDCl3) δ 166.57, 
138.86, 132.87, 131.00, 129.18, 128.60, 128.41, 127.46, 126.82, 124.41, 120.06, 116.25; 
HRMS (EI) calcd for C20H12NOF3: 339.0871, found 339.0876.  
 
9-(Thiophenylcarbonyl)carbazole (37): light yellow solid, mp 95-98 °C; 1H NMR (300 
MHz, CDCl3) δ 8.04-8.01 (m, 2H), 7.76-7.70 (m, 3H), 7.60 (d, J = 3.0 Hz, 1H), 7.39-7.36 
(m, 4H), 7.16 (dd, J = 6.0, 3.0 Hz, 1H); 13C NMR (300 MHz, CDCl3) δ 162.98, 139.37, 
137.98, 133.95, 133.38, 127.87, 126.82, 125.63, 123.45, 120.13, 115.46; HRMS (EI) 
calcd for C17H11NOS: 277.0561, found 277.0564.  
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2-Methyl-9-(4-methoxybenzoyl)carbazole (38): white solid, mp 129-131 °C; 1H NMR 
(300 MHz, CDCl3) δ 7.98 (d, J = 6.0 Hz, 1H), 7.90 (d, J = 9.0 Hz, 1H), 7.74 (d, J = 9.0 
Hz,  2H), 7.54 (s, 1H), 7.40-7.24 (m, 3H), 7.19 (d, J = 9.0 Hz, 1H), 7.01 (d, J = 9.0 Hz, 
2H), 3.93 (s, 3H), 2.46 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 169.34, 163.38, 139.98, 
139.47, 137.16, 132.03, 127.79, 126.12, 124.62, 123.60, 123.10, 119.75, 119.63, 116.05, 
115.62, 114.23; HRMS (EI) calcd for C21H17NO2: 315.1259, found 315.1266. 
 
3-Methyl-9-(4-methoxybenzoyl)carbazole (39): light brown oil; 1H NMR (300 MHz, 
CDCl3) δ 7.99 (dd, J = 6.0, 3.0 Hz, 1H), 7.82 (s, 1H), 7.73 (d, J = 9.0 Hz, 2H), 7.60 (dd, J 
= 6.0, 3.0 Hz, 1H), 7.42(d, J = 9.0 Hz, 1H), 7.37-7.33 (m, 2H), 7.16 (d, J = 9.0 Hz, 1H), 
7.00 (d, J = 9.0 Hz, 2H), 3.92 (s, 3H), 2.52 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
169.22, 163.27, 139.76, 137.67, 132.89, 131.87, 129.16, 128.59, 127.96, 126.66, 126.00, 
123.19, 120.05, 119.91, 115.81, 114.24, 55.71, 21.51; HRMS (EI) calcd for C21H17NO2: 
315.1257, found 315.1263. 
 
4-Methyl-9-(4-methoxybenzoyl)carbazole (40): light brown oil; 1H NMR (400 MHz, 
CDCl3) δ 8.18 (m, 1H), 7.91 (d, J = 8.4 Hz, 1H), 7.74 (d, J = 8.8 Hz, 2H), 7.65 (m, 1H), 
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7.44 (d, J = 8.4 Hz, 1H), 7.34-7.23 (m, 2H), 7.18-7.13 (m, 1H), 7.00 (d, J = 8.8 Hz, 2H); 
13C NMR (300 MHz, CDCl3) δ 169.34, 163.44, 140.54, 139.56, 133.05, 132.11, 129.75, 
126.48, 126.30, 126.04, 124.85, 123.04, 122.59, 122.42, 115.31, 114.24, 113.08, 55.77, 
21.18; HRMS (EI) m/z calcd for C21H17NO2: 316.13321, found 316.13346. 
 
2,3-Dimethyl-9-(4-methoxybenzoyl)carbazole (41): white solid, mp 156-157 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.95 (d, J = 9.0 Hz, 1H), 7.76 (s, 1H), 7.72 (d, J = 9.0 Hz, 
2H), 7.47 (s, 1H), 7.38 (d, J = 9.0 Hz, 1H), 7.32-7.23 (m, 2H), 6.99 (d, J = 9.0 Hz, 2H), 
3.92 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 169.05, 163.26, 139.44, 138.30, 136.02, 
131.92, 138.30, 136.02, 132.06, 131.92, 127.98, 126.23, 126.01, 123.99, 123.08, 120.39, 
119.65, 116.51, 115.71, 114.20, 55.74, 21.06, 20.22; HRMS (EI) m/z calcd for 
C20H14N2O3: 330.14886, found 330.14919.  
 
2-Methoxy-9-(4-methoxybenzoyl)carbazole (42): white solid, mp 109-111 °C; 1H NMR 
(300 MHz, CDCl3) δ 7.92-7.86 (d, J = 9.0 Hz, 2H), 7.73 (d, J = 9.0 Hz, 2H), 7.37-7.22 
(m, 4H), 7.01-6.94 (m, 3H), 3.91 (s, 3H), 3.79 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
169.38, 163.40, 159.43, 140.86, 139.43, 131.98, 127.66, 126.13, 125.32, 123.24, 120.57, 
119.43, 119.24, 115.54, 114.27, 111.84, 100.32, 55.73; HRMS (EI) calcd for C21H17NO3: 
331.1208, found 331.1216.  
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3-Methoxy-9-(4-methoxybenzoyl)carbazole (43): light brown oil; 1H NMR (300 MHz, 
CDCl3) δ 8.17 (d, J = 9.0 Hz, 1H), 7.76 (d, J = 15.0 Hz, 1H), 7.63 (d, J = 6.0 Hz, 1H), 
7.44-7.41 (m, 3H), 7.35-7.29 (m, 1H), 7.23-7.20 (m, 1H), 7.11 (d, J = 15.0 Hz, 1H), 7.00 
(d, J = 9.0 Hz, 2H), 3.91 (s, 3H), 3.84 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.58, 
161.91, 155.85, 138.55, 134.58, 129.84, 125.99, 122.45, 120.84, 120.44, 119.23, 118.10, 
115.51, 115.26, 111.50, 110.95, 103.38, 56.30; HRMS (EI) calcd for C21H17NO3: 
331.1209, found 331.1215.  
 
2,3-Dimethoxy-9-(4-methoxybenzoyl)carbazole (44): white solid, mp 114-116 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.89 (d, J = 9.0 Hz, 1H), 7.73 (d, J = 9.0 Hz, 2H), 7.43 (s, 
1H), 7.42 (s, 1H), 7.32-7.17 (m, 4H), 7.01 (d, J = 9.0 Hz, 2H), 4.03 (s, 3H), 3.92 (s, 3H), 
3.85 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 169.19, 163.26, 149.25, 146.82, 139.10, 
134.03, 131.87, 127.88, 126.40, 125.12, 123.15, 119.04, 118.32, 115.69, 114.25, 101.66, 
99.84, 56.54, 56.21, 55.75; HRMS (EI) calcd for C22H19NO4: 361.1314, found 361.1318.  
 
3-Bromo-9-(4-methoxybenzoyl)carbazole (45): white solid, mp 110-112 °C; 1H NMR 
(300 MHz, CDCl3) δ 8.14 (s, 1H), 7.99-7.96 (m, 1H), 7.72 (d, J = 9.0 Hz, 2H), 7.52-7.42 
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(m, 3H), 7.38-7.35 (m, 2H), 7.01 (d, J = 6.0 Hz, 2H), 3.93 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 166.58, 163.62, 139.81, 138.30, 132.05, 129.55, 127.80, 127.50, 127.31, 
124.76, 123.51, 122.90, 120.25, 117.20, 116.38, 115.76, 114.40, 55.79; HRMS (EI) calcd 
for C20H14NO2Br: 379.0208, found 379.0206.  
 
3-Chloro-9-(4-methoxybenzoyl)carbazole (46): light brown oil; 1H NMR (300 MHz, 
CDCl3) δ 7.98-7.96 (m, 2H), 7.72 (d, J = 9.0 Hz, 2H), 7.56-7.49 (m, 1H), 7.37-7.29 (m, 
3H), 7.01 (d, J = 9.0 Hz, 2H), 3.93 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 169.03, 
163.59, 139.95, 137.90, 132.02, 129.18, 128.85, 127.46, 126.84, 124.90, 123.47, 120.66, 
120.25, 119.85, 116.81, 115.79, 114.39, 55.78; HRMS (EI) calcd for C20H14NO2Cl: 
335.0713, found 335.0715.  
 
2-Chloro-9-(4-methoxybenzoyl)carbazole (47): white solid, mp 93-95 °C; 1H NMR 
(300 MHz, CDCl3) δ 7.98 (m, 1H), 7.93 (d, J = 8.4 Hz, 1H), 7.77-7.72 (dd, J = 8.4, 1.8 
Hz, 3H), 7.42 (d, J = 3.0 Hz, 1H), 7.35-7.32 (m, 3H), 7.02 (d, J = 9.0 Hz, 2H), 3.93 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 169.02, 163.68, 143.54, 139.07, 132.08, 130.71, 
129.17, 128.60, 126.89, 124.43, 123.79, 123.42, 120.73, 120.06, 116.00, 115.65, 114.40, 
55.79; HRMS (EI) m/z calcd for C20H14NO2Cl: 336.07858, found 336.07904.  
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3-Fluoro-9-(4-methoxybenzoyl)carbazole (48): white solid, mp 90-93 °C; 1H NMR (300 
MHz, CDCl3) δ 7.98-7.95 (m, 1H), 7.72 (d, J = 9.0 Hz, 2H), 7.69-7.60 (m, 2H), 7.48-7.45 
(m, 1H), 7.36-7.33 (d, J = 6.0 Hz, 2H), 7.09 (td, J = 9.0, 2.7 Hz, 1H), 7.02 (d, J = 6.9 Hz, 
2H); 13C NMR (300 MHz, CDCl3) δ 169.09, 163.48, 157.92, 140.21, 131.95, 127.55, 
127.36, 123.30, 120.19, 116.95, 116.84, 115.88, 114.50, 114.37, 114.17, 106.17, 105.85, 
55.77; HRMS (EI) m/z calcd for C20H14NO2F: 320.10813, found 320.10895.  
 
2-Fluoro-9-(4-methoxybenzoyl)carbazole (49): white solid, mp 115-117 °C; 1H NMR 
(300 MHz, CDCl3) δ 7.98-7.92 (m, 2H), 7.73 (d, J = 9.0 Hz, 2H), 7.44-7.41 (m, 2H), 7.32 
(td, J = 9.0, 3.0 Hz, 2H), 7.11 (d, J = 6.0 Hz, 1H), 7.02 (d, J = 9.0 Hz, 2H), 3.93 (s, 3H); 
13C NMR (300 MHz, CDCl3) δ 169.13, 163.63, 160.51, 143.54, 140.24, 132.01, 129.17, 
128.60, 126.30, 125.61, 123.45, 120.74, 119.75, 115.62, 114.41, 55.77; HRMS (EI) calcd 
for C20H14NO2F: 319.1009, found 319.1010.  
 
9-(4-Methoxybenzoyl)-3-(trifluoromethyl)carbazole (50): light brown oil; 1H NMR 
(300 MHz, CDCl3) δ 8.20-8.17 (m, 2H), 7.44-7.38 (m, 3H), 7.32 (dd, J = 5.1, 3.0 Hz, 
1H), 7.30-7.21 (m, 3H), 7.10 (d, J = 8.7 Hz, 2H), 3.91 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 165.09, 164.05, 148.23, 143.51, 132.46, 130.69, 130.46, 129.61, 129.15, 
128.92, 128.58, 126.12, 125.89, 125.60, 122.04, 121.98, 120.62, 120.56, 118.25, 114.01, 
55.70; HRMS (EI) calcd for C21H14NO2F3: 369.0975, found 369.0977.  
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9-(4-Methoxybenzoyl)-2-(trifluoromethyl)carbazole (51): white solid, mp 107-109 °C; 
1H NMR (300 MHz, CDCl3) δ 8.14-8.06 (m, 3H), 7.74 (d, J = 9.0 Hz, 2H), 7.63 (d, J = 
9.0 Hz, 1H), 7.44-7.38 (m, 3H), 7.03 (d, J = 9.0 Hz, 2H), 3.94 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 169.02, 163.82, 138.98, 138.36, 132.14, 130.49, 129.18, 128.61, 127.88, 
126.97, 125.61, 123.54, 120.74, 120.67, 120.32, 115.74, 114.45, 55.83; HRMS (EI) calcd 
for C21H14NO2F3: 369.0977, found 369.0978.  
 
3-Cyano-9-(4-methoxybenzoyl)carbazole (52): white solid, mp 175-177 °C; 1H NMR 
(300 MHz, CDCl3) δ 8.35 (s, 1H), 8.08-8.05 (m, 1H), 7.76-7.70 (m, 3H), 7.63 (dd, J = 
9.0, 3.0 Hz, 1H), 7.50-7.40 (m, 3H), 7.03 (d, J = 9.0 Hz, 2H), 3.94 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 168.88, 164.09, 141.60, 140.07, 132.35, 130.08, 128.13, 126.60, 126.21, 
124.69, 124.24, 123.91, 120.52, 119.69, 116.25, 115.68, 114.57, 106.40, 55.86; HRMS 
(EI) calcd for C21H14N2O2: 326.3481, found 326.3468.  
 
3-Carbomethoxy-9-(4-methoxybenzoyl)carbazole (53): white solid, mp 134-135 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.75 (s,  1H), 8.11-8.04 (m, 2H), 7.75 (d, J = 9.0 Hz, 2H), 
7.60 (d, J = 9.0 Hz, 1H), 7.54 (t, J = 3.6 Hz, 1H), 7.41-7.38 (m, 2H), 7.01 (d, J = 9.0 Hz, 
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2H), 3.99 (s, 3H), 3.94 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 169.13, 167.37, 163.82, 
141.73, 140.10, 132.26, 129.01, 128.16, 127.42, 125.85, 125.44, 125.01, 123.66, 122.19, 
120.42, 115.67, 115.22, 114.44, 55.82, 52.41; HRMS (EI) calcd m/z for C22H17NO4: 
360.12303, found 360.12378.  
 
9-(4-Methoxybenzoyl)-3-nitrocarbazole (54): yellow solid, mp 170-172 °C; 1H NMR 
(300 MHz, CDCl3) δ 8.94 (d, J = 2.1 Hz, 1H), 8.28 (dd, J = 9.0, 2.4 Hz, 1H), 8.14-8.11 
(m, 1H), 7.78-7.71 (d, J = 9.0 Hz, 3H), 7.48-7.42 (m, 3H), 7.03 (d, J = 9.0 Hz, 2H), 3.95 
(s, 3H); 13C NMR (300 MHz, CDCl3) δ 168.81, 166.58, 164.21, 143.69, 142.89, 140.64, 
132.43, 128.29, 126.39, 126.06, 124.67, 124.03, 122.19, 120.75, 116.38, 115.75, 115.48, 
114.61, 55.87; HRMS (EI) m/z calcd for C20H14N2O4: 347.10263, found 337.10329.  
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GENERAL CONCLUSIONS 
    In this dissertation, several novel aryne reactions have been investigated. The scope, 
limitations, and applications of these reactions are presented in detail. The reactions 
involve three major areas of aryne chemistry and show the versatility of arynes. 
    Chapter 1 reports the synthesis of a variety of biologically interesting 9-substituted 
xanthenes involving the reaction of arynes and o-hydroxychalcones. This chemistry 
presumably proceeds by intermolecular nucleophilic attack of the phenoxide of the 
chalcone on the aryne and subsequent intramolecular Michael addition. The introduction 
of an external base, Cs2CO3, has proven beneficial to this reaction.  
Chapter 2 describes a 1,3-dipolar cycloaddition reaction of arynes and nitrones. 
Substituted benzisoxazolines were easily synthesized under mild reaction conditions. A 
variety of functional groups are well tolerated in this process, allowing for the facile 
synthesis of more complicated molecules.     
Chapter 3 discusses a novel synthesis of phenanthridinones, which involves the 
palladium-catalyzed annulation of arynes by 2-halobenzamides. This method provides an 
efficient synthesis of substituted phenanthridinones from readily available starting 
materials. Both C-C and C-N bonds are formed simultaneously and a variety of functional 
groups are tolerated in this reaction, making further elaboration possible.  
   Chapter 4 reports a novel synthesis of N-acylcarbazoles, which involves the palladium-
catalyzed annulation of arynes by 2-haloacetanilides. This methodology provides this 
important heterocyclic ring system in a single step by simultaneous C-C and C-N bond 
formation. This process has been shown to be tolerant of multiple functional groups, 
making further elaboration possible. 
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